1. Introduction
Electrophoretic mobility enables precise control of charged and uncharged biocolloids in drug delivery, thereby improving transport efficiency and targeted therapeutic outcomes (Bhowmik et al. Reference Bhowmik, Gopinath, Kumar, Duraivel and Kumar2012; Liu et al. Reference Liu, Shah and Tan2012; Dey et al. Reference Dey, Raja Sekhar and Burada2018). In gel electrophoresis, the hydrogel acts as a charged porous medium that modulates biocolloid mobility through size-induced drag, surface charge (Bhattacharyya & De Reference Bhattacharyya and De2016) and biochemical changes induced by ligand-receptor interactions (Alexis et al. Reference Alexis, Pridgen, Molnar and Farokhzad2008). A common strategy is to use surface-functionalised biocolloids (Hsu et al. Reference Hsu, Huang and Tseng2013), such as biological cells, synthetic polymers or silica spheres embedded in a standard polymer-based hydrogel for controlled interactions and tailored separation. Hydrogels are three-dimensional, cross-linked, water-insoluble networks made from natural or synthetic polymers and/or monomers that give them a remarkable capacity to absorb both water and biological fluids (El Sayed Reference El Sayed2023). A composite hydrogel is a blend of natural and synthetic biomaterials that is engineered to mimic the natural extracellular matrix. This combination offers high biocompatibility, enhanced mechanical properties and functionality for effective skin tissue regeneration (Omidian et al. Reference Omidian, Akhzarmehr and Dey Chowdhury2024). These are formed by integrating hydrophilic groups – such as hydroxyl (–OH), carboxylic acid (–COOH) and amine (–NH2) – into the polymer chain’s backbone in the presence of additives such as kaolin, zeolite, etc., thereby enhancing their properties. Significant efforts have been made to synthesise polymer-based composite hydrogels using physical or chemical cross-linking techniques to enhance their physicochemical and biological properties (El Sayed Reference El Sayed2023). Non-deformable hydrogels are advantageous for gel electrophoresis because their stable porous network provides a consistent sieving matrix, enabling the physical separation of various molecules/biocolloids based on their sizes during the migration under an electric field (Lee et al. Reference Lee, Costumbrado, Hsu and Kim2012). In this context, applying a weak electric field to transport compounds across the skin via electrophoresis represents a promising method for transdermal drug delivery (Pikal Reference Pikal2001; Prausnitz & Langer Reference Prausnitz and Langer2008). Moreover, the negatively charged skin tissue facilitates transdermal drug delivery (Baspinar & Borchert Reference Baspinar and Borchert2012). One may consider such a biological tissue as a charged hydrogel (Kwon et al. Reference Kwon, Yasuda, Gong and Ohmiya2014; Tanikawa et al. Reference Tanikawa2023), where the polymeric matrix defines the porosity (available void space) and the interconnected structure determines the permeability. Permeability varies across biological tissues – low in brain tissue due to tightly packed extracellular structures, and higher in connective and nerve tissues with more open matrices, resulting in a controlled drug distribution, penetration and retention of drug carriers (Osamura et al. Reference Osamura, Zhao, Zobitz, An and Amadio2007; Zhan et al. Reference Zhan, Rodriguez y Baena and Dini2019; Yang & Zhan Reference Yang and Zhan2022).
Electrophoresis of a charged biocolloid through a hydrogel medium can be modelled using the Brinkman equation, considering the hydrodynamic coupling of the electro-osmotic flow with the polymer skeleton of the hydrogel (Hill Reference Hill2006b ; Hill & Ostoja-Starzewski Reference Hill and Ostoja-Starzewski2008; Tsai et al. Reference Tsai, Huang and Lee2011; Hsu et al. Reference Hsu, Lin, Yeh and Lin2012, Reference Hsu, Huang and Tseng2013; Li & Hill Reference Li and Hill2013; Bhattacharyya et al. Reference Bhattacharyya, De and Gopmandal2014; Hill Reference Hill2015; Bhattacharyya & De Reference Bhattacharyya and De2016; Hill Reference Hill2022). These models accurately capture the viscous effects and flow resistance caused by the porous hydrogel structure, which is essential for representing the fluid dynamics within hydrogel-based microfluidic devices. The cross-linked polymeric network provides a viscous resistance to solvent flow, while maintaining an open porous structure that governs drug release in a controlled manner (Li & Mooney Reference Li and Mooney2016; Raeisi & Farjadian Reference Raeisi and Farjadian2024). Additionally, the Brinkman model provides a consistent transition between Stokes flow (in the limit of large permeability) and Darcy flow (in the limit of small permeability), making it more suitable for describing electro-hydrodynamic interactions in charged porous media relevant to controlled drug release and microfluidic applications (Chakrapani et al. Reference Chakrapani, Bazyar, Lammertink, Luding and den Otter2023). Therefore, understanding the controlled electrophoresis of a slightly deformed, charged spherical biocolloid in a porous hydrogel medium is key to designing an efficient targeting system capable of reaching a specific site through a precise screening process.
Theoretical studies by Ohshima (Reference Ohshima2002), Khair & Squires (Reference Khair and Squires2009), Li & Koch (Reference Li and Koch2020) on electrophoresis have primarily centred on spherical biocolloids with uniform surface charge density. However, it is essential to recognise that moving biocolloids may possess non-uniformly distributed surface charges in practical scenarios owing to natural induction or external imposition (Ghosh & Chakraborty Reference Ghosh and Chakraborty2016; Ghosh et al. Reference Ghosh, Mukherjee and Chakraborty2021). Anderson (Reference Anderson1985, Reference Anderson1989) reported the possible occurrence of non-uniform charge density on biocolloid surfaces in phenomena such as hetero-coagulation and crystallinity. Various inorganic biocolloids considered by Van Riemsdijk et al. (Reference Van Riemsdijk, Bolt, Koopal and Blaakmeer1986), Amro et al. (Reference Amro, Kotra, Wadu-Mesthrige, Bulychev, Mobashery and Liu2000), as well as biocolloids with adsorbed surfactant considered by Fleming et al. (Reference Fleming, Wanless and Biggs1999), may inherently exhibit a non-uniform surface charge density. In recent research, Janus biocolloids have emerged as a concept for the artificial engineering of biocolloids with heterogeneous surface properties, resulting in non-uniform surface charge and other characteristics (Molotilin et al. Reference Molotilin, Lobaskin and Vinogradova2016). Fair & Anderson (Reference Fair and Anderson1989), Fair (Reference Fair1990), Yariv (Reference Yariv2005) investigated the mobility of non-spherical biocolloids when the non-uniform surface charge impacts electrophoretic mobility. In the case of non-spherical biocolloids (cylinders, ellipses, plates, etc.), the excess charge does not distribute itself uniformly. Instead, it tends to concentrate more in regions with higher curvature (Cade & Owen Reference Cade and Owen1985; Curtright et al. Reference Curtright, Cao, Huang, Sarmiento, Subedi, Tarrence and Thapaliya2020). The non-uniform biocolloid surface charge density must be accounted for when analysing the mobility of non-spherical biocolloids. Geometry-dependent biocolloid (with non-uniform surface charge) adsorption in electrophoresis plays a crucial role depending on the bioavailability and solubility (Liu et al. Reference Liu, Shah and Tan2012) of the targeted tumour region in the drug delivery model and microfluidic chips (Chang & Yeo Reference Chang and Yeo2010). Drug-loaded non-spherical nano-biocolloids are typically designed with stability in mind (Dasgupta et al. Reference Dasgupta, Auth and Gompper2014) as well as well-defined charge characteristics that enable predictable responses to external electric fields.
In gel electrophoresis, a biocolloid’s electrophoretic mobility is significantly influenced by its size relative to the hydrogel polymer pore size. When the biocolloid size is much smaller than the pore size of the polymer network of the hydrogel, the biocolloid mobility approaches that found in a pure solvent. When biocolloid and pore sizes are comparable, a significantly reduced mobility of tracer biocolloids can be expected (Grimm et al. Reference Grimm, Nowak, Hoffmann and Schartl2009). However, movement is also affected by the charge on the biocolloid surface, surface coatings, electrolyte concentration and the hydrogel charge (Allison et al. Reference Allison, Xin and Pei2007; Hanauer et al. Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007; Doane et al. Reference Doane, Cheng, Babar, Hill and Burda2010). To the best of our knowledge, the electrophoresis of slightly deformed spherical biocolloids with non-uniform surface charge distributions remains underexplored. Smaller biocolloids can more effectively evade the body’s natural clearance mechanisms, thereby prolonging their circulation in the bloodstream (Robertson et al. Reference Robertson, Rizzello, Avila-Olias, Gaitzsch, Contini, Magoń, Renshaw and Battaglia2016). Moreover, shape plays a crucial role in biocolloid interaction with cells. For example, cylindrical biocolloids interact differently than spherical ones, leading to changes in bioavailability (Robertson et al. Reference Robertson, Rizzello, Avila-Olias, Gaitzsch, Contini, Magoń, Renshaw and Battaglia2016). The previous information motivates us to consider the shape effect in gel electrophoresis, extending the analysis beyond biocolloids to encompass a broad range of natural or synthetic biocolloids. In this context, our attention turns to the studies of Prakash & Keh (Reference Prakash and Keh2023, Reference Prakash and Keh2024), which consider a spherical particle with a slightly deformed shape and spheroidal shape, respectively, in viscous flow.
In this study, we aim to enhance our understanding of the intricate biophysical aspects of biocolloid migration, in which the shape-deformation parameter influences the interplay between hydrodynamic and electric forces, thereby altering the surrounding fluid flow dynamics. Our study has the potential to transform the understanding and control of the size selectivity of synthetic biocolloids. These biocolloids are artificially created from biocompatible materials used in various applications, including drug delivery, tissue engineering and diagnostics (Hasan et al. Reference Hasan, Morshed, Memic, Hassan, Webster and Marei2018; Ellakwa & Ellakwa Reference Ellakwa and Ellakwa2025). They often contain polymers such as poly(lactic acid) (PLA) or polyethylene glycol (PEG) (Satchanska et al. Reference Satchanska, Davidova and Petrov2024). Therefore, one of the primary objectives of the study reported in the current manuscript is to demonstrate the shape- and size-selectivity of charged biocolloids via electrophoresis in a charged hydrogel medium. The present study aims to relate the non-uniform behaviour of the biocolloid’s surface charge density to its slightly deformed shape via the shape deformation parameter. We seek a range of surface charge densities for which a biocolloid can be designed to achieve optimal clinical outcomes. Moreover, the size selectivity of the biocolloids is expected to depend on the nature of the fixed charges attached to the polymer skeleton of the hydrogel, and the hydrogel pore size is linked to the permeability through the characteristic pore-scale length
$\ell =\sqrt {k}$
, which reflects permeability variations across biological domains. For typical hydrogels with pore sizes at the nanoscale in the range
$\ell \sim 5{-}200\,\mathrm{nm}$
(Stellwagen & Stellwagen Reference Stellwagen and Stellwagen2009; Lazarenko et al. Reference Lazarenko, Zabashta, Honcharuk, Alekseev, Yablochkova, Vergun, Andrusenko, Lazarenko and Bulavin2025) and the low to moderate ionic concentration of the added symmetric monovalent electrolyte (of the order
$10^{-3}{-}10^{-1}$
mM) (Hanauer et al. Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007), the porosity lies in the range
$0.85 \lesssim \varepsilon \lesssim 0.98$
. Consideration of such biocolloids exhibits a significant electrophoretic mobility in a linearised Poisson–Boltzmann framework under weak electrostatic potential assumption, which is equal to the
$\zeta$
potential at the biocolloid surface, yielding an approximate value
$|{\zeta }|\le 25$
mV, while keeping the electric field strengths as low as
$25{-}50\,\text{V cm}^{-1}$
(Khobaib et al. Reference Khobaib, Mikkelsen, Vincent-Dospital and Rozynek2021), facilitating controlled drug distribution in biological tissues with minimal cellular damage (Nakamura et al. Reference Nakamura, Okamura, Tajima, Kawano, Yamaji, Ohsaki and Watano2023). Consequently, suitable ranges for the model parameters are incorporated to ensure physical relevance while both maintaining consistency in the context of targeted drug delivery using biocolloids, and also successfully describing the limiting regime analysis through combined Brinkman hydrodynamic and electrostatic effect (in thin and thick Debye layer analysis). They are designed to remain in the circulatory system for a prolonged duration and to maintain a low surface charge through controlled surface modification. Furthermore, this model successfully recovers the limiting hydrodynamic regimes corresponding to Stokes and Darcy flow, as well as the electrostatic limits associated with thin and thick Debye layers, thereby supporting the robustness and consistency of the present formulation.
2. Mathematical formulation
The electrophoresis of a ‘charged synthetic biocolloid’ in an electrolyte solution involves three interdependent coupled physical processes: electrostatic interactions, hydrodynamic drag and ionic diffusion. In gel electrophoresis, a biocolloid migrates through a charged hydrogel under these three processes. The shape of the biocolloid is considered here as a slightly deformed sphere. A comprehensive analysis of this motion necessitates a profound understanding of the underlying physical and chemical principles. We use the term ‘charged synthetic biocolloid’, or simply ‘biocolloid’, because it is a generic term that reflects its broad range of uses in biotechnology and biochemistry. In this work, the slightly deformed biocolloid can be represented as a domain in
$\mathbb{R}^{3}$
which is given as
with the boundary surface
and
$\partial \mathbb{S}_{{{U}}}$
is the boundary surface with respect to undeformed geometry.
Schematic diagram of the problem geometry representing the migration of biocolloid along the
$z$
-axis through a non-deforming charged gel-like medium.

Figure 1. Long description
A diagram of the problem geometry representing the migration of a biocolloid along the x-axis through a non-deforming charged gel-like medium. The diagram shows an undeformed spherical biocolloid moving through the medium. The electric field direction is indicated as E∞ in the z-axis direction, and the fluid velocity direction is indicated as U∞ in the z-axis direction. The charged particle, or biocolloid, is depicted as a sphere with a radius given by the equation r = a(1 + εg1(θ, φ)). The charged hydrogel medium is represented as a Brinkman type medium.
Here, the origin of spherical coordinates
$(r,\theta ,\varphi )$
is attached to the centre of the undeformed spherical biocolloid of radius
$a$
(see figure 1). The parameter
$\epsilon$
is a small dimensionless parameter (
$\epsilon \ll 1$
) that represents the deformation of the biocolloid from its spherical shape. The function
$g_1(\theta ,\varphi )$
is an arbitrary function of angular and azimuthal positions
$\theta$
and
$\varphi$
, respectively. The parameter
$\epsilon$
, an artificial construct, is necessarily intertwined with
$g_1(\theta ,\varphi )$
and guides towards the order of approximation of the final results. The function
$g_1(\theta ,\varphi )$
can, in general, be expanded in a series of spherical harmonics. In general, the surface equation of the biocolloid is given by
The surface of a spheroidal biocolloid in Cartesian coordinates
$(x,y,z)$
is given by
where
$a$
is the equatorial radius of the spheroid and
$b$
is the distance from the centre to the pole. For
$b/a \lt 1$
, the biocolloid is an oblate spheroid and for
$b/a \gt 1$
, it is a prolate spheroid. If we assume that
$b/a=1-\epsilon$
, then
$0\lt \epsilon \lt 1$
corresponds to an oblate spheroidal biocolloid and
$-1\lt \epsilon \lt 0$
corresponds to a prolate spheroidal biocolloid. The case
$\epsilon = 0$
represents a spherical biocolloid of radius
${r}=a$
. It can easily be shown that when
$\epsilon \ll 1$
, a Taylor series expansion with respect to
${r}=a$
can be used to express the shape of the spheroidal biocolloid in the form of (2.2a
), where
$g_1(\theta ,\varphi )$
has the following form in terms of spherical harmonics:
\begin{align} g_1(\theta ,\varphi ) = \displaystyle \sum _{n=1}^{\infty }{\mathcal{G}_{nk}Y_n(\theta ,\varphi )}, \end{align}
where
$\mathcal{G}_{nk}$
are constants and
\begin{align} {Y_n(\theta ,\varphi )}=\displaystyle \sum _{m=0}^{n}{P^{m}_{n}(\cos (\theta ))}({M_{nm}\cos (m\varphi )}+{N_{nm}\sin m\varphi }). \end{align}
The unit outward normal
$\boldsymbol{n}$
on the biocolloid surface is obtained as
where
$\boldsymbol{n}$
can be expanded in the powers of
$\epsilon$
. Accordingly, we expand
$\boldsymbol {\nabla }{G}$
in a Taylor series with respect to the undeformed geometry of
$\mathbb{S}$
in (2.2a
), leading to the following expression for
$\boldsymbol{n}$
:
where
Consideration of the slightly deformed spherical structure of the biocolloid
$\mathbb{S}$
leads to a non-uniform surface charge density, whose generic form would be
where
$\sigma _0$
represents the uniform surface charge density of the undeformed shape of
$\mathbb{S}$
, while
$\sigma '$
represents the additional surface charge density caused by the slight deformation such that
$\sigma '\rightarrow 0$
as
$\epsilon \rightarrow 0$
.
Counterions are concentrated more densely near the charged surface of the biocolloid, where maintaining a distance from the surface is conducive to ionic electroneutrality (Masliyah & Bhattacharjee Reference Masliyah and Bhattacharjee2006; Hennessy et al. Reference Hennessy, Celora, Waters, Münch and Wagner2024). Nevertheless, a comprehensive understanding of the counterion and co-ion distributions, both in proximity to and at distances from the charged surface, and of the extent to which the charged surface influences their spatial distribution warrants further elucidation. We assume that the biocolloid migrates through the charged hydrogel
$\mathbb{R}^{3} \diagdown \mathbb{S}$
under the action of a weak electric field. Moreover, at low applied field strengths, the biocolloid velocity is linearly proportional to the strength of the field. Furthermore, no ions can penetrate
$\partial \mathbb{S}$
as the biocolloid is solid. These assumptions are fundamental to our analysis and significant in ensuring the accuracy and validity of our findings. To facilitate analysis, the equations are written in a stationary reference frame with respect to the biocolloid. Consequently, it is assumed that the biocolloid is at rest while the liquid, which is moving away from it, has a uniform speed and the biocolloid is also assumed not to rotate.
In this study, we examine the electrical response of a charged biocolloid with a slightly deformed spherical shape in terms of electrophoretic mobility when immersed in an electrically charged hydrogel. The gel is treated as a homogeneous Brinkman medium with Darcy permeability
$\ell ^{2}$
(also referred to as Brinkman screening length) and is filled with an aqueous electrolyte. The hydrogel skeleton is a negatively charged polymer network with a uniform distribution of fixed charges. However, the aqueous electrolyte contains mobile counterions of the polymer network and the added salt, and is treated as an incompressible Newtonian aqueous solvent. The motion of electrolytes at the micro- and nanoscale has negligible inertial effects because of their low speeds. Ions are classified as fixed or mobile, with the fixed charge bound to the polymer skeleton. The mobile ions include
$M$
species of counterions of the fixed charge and
$N$
species of ions from the added salt. The countercharge from the electrolyte medium becomes located in a diffuse layer on the surface
$\partial \mathbb{S}$
of the biocolloid with a thickness equal to the Debye length
$\kappa ^{-1}$
. The ion concentration in the electrolyte, the surface charge density and the molecule radius determine the electrostatic potential
$\varPsi$
on the inclusion. The electrostatic potential
$\varPsi$
satisfies the following Poisson equation:
where
$\rho _{{{m}}}$
and
$\rho _{\!f}$
are the mobile and fixed charge densities, respectively;
$\varepsilon _0$
,
$\varepsilon _s$
denote the vacuum permittivity and the dielectric constant of the solvent electrolyte, respectively; and
$\rho _{{{{T}}}}$
denotes the total charge density.
Let
$ n^{{{m}}}_{\!j}$
and
$ n^{{{f}}}_{\!j}$
denote the concentration of the
$j$
th mobile charge species within the hydrogel solvent and the
$ j$
th fixed charge species on the polymer skeleton, respectively, with their corresponding valences
$z^{{{m}}}_{\!j}$
and
$z^{{ {f}}}_{\!j}$
, and with
$e$
denoting the elementary charge. The steady conservation of mobile ions
$n^{{{m}}}_{\!j}$
satisfies the Nernst–Planck equation, which arises from the balance of fluxes corresponding to mobile ion diffusion, convection and transport driven by the electrostatic potential gradient
\begin{align} \boldsymbol{J}_{\!j}=-D_{\!j}\left (\boldsymbol{\nabla } {n^{{{m}}}_{\!j}}+\frac {{z^{{{m}}}_{\!j}e{n^{{{m}}}_{\!j}}}}{k_{{{B}}}T}\boldsymbol{\nabla } \varPsi \right )+n^{{{m}}}_{\!j}\boldsymbol{u}\quad \textrm {and}\quad \boldsymbol{\nabla }\boldsymbol{\cdot }\boldsymbol{J}_{\!j}=0, \end{align}
where
$\boldsymbol{J}_{\!j}$
is the total ionic flux as previously mentioned,
$D_{\!j}$
is the mobile ion diffusivity,
$k_{{{B}}} T$
is the thermal energy (
$k_{{{B}}}$
is the Boltzman constant and
$T$
is the temperature in Kelvin scale) and
$\boldsymbol{u}$
is the solvent velocity. The dynamics of mobile ions convection (in (2.6)) within the hydrogel medium is governed by electrolyte solvent velocity that satisfies the following momentum and mass balance equations:
where
$p$
is the solvent pressure, and
$-\eta \ell ^{-2}\boldsymbol{u}$
and
$-\rho _{{{m}}}\boldsymbol{\nabla }\varPsi$
are the Darcy drag force and electrostatic body force acting on the hydrogel solvent, respectively. The problem can also be discussed in such a way that the gel electrophoresis is superimposed into two dynamic cases: (i)
$\boldsymbol{U}$
-problem and (ii)
$\boldsymbol{E}$
-problem. In the subsequent sections, we present these problems separately and apply the appropriate boundary conditions to the deformed biocolloid surface. Solutions of the
$\boldsymbol{U}$
- and
$\boldsymbol{E}$
-problems enable us to calculate the electrophoretic mobility (
$\mu _{{{E}}}$
). Under the assumption that the applied electric field is proportional to the hydrodynamic field,
$\mu _{{{E}}}$
is defined as
$\mu _{{{E}}}=\mid \boldsymbol{U}\mid /\mid \boldsymbol{E}\mid$
.
2.1.
$\boldsymbol{U}$
-problem
The
$\boldsymbol{U}$
-problem involves fluid flow around the biocolloid without an electric field
$\boldsymbol{E}=\boldsymbol{0}$
. Even though the biocolloid and the surrounding electrolyte solution are charged, we ignore all the contributions from the electrokinetic influences because these are weak compared with the purely hydrodynamic viscous force exerted by the fluid on the biocolloid. The corresponding fluid velocity and pressure satisfy the Brinkman equation, together with the equation of continuity, given as
The following boundary conditions are employed at the biocolloid surface and far field. Here, the reference frame is attached to the centre of the biocolloid that translates with a constant velocity
$\boldsymbol{U}$
which is equivalent to
The boundary
$\partial \mathbb{S}$
represents the solid surface of the biocolloid, which is assumed to be rigid and impenetrable. The fluid velocity
$\boldsymbol{u}$
satisfies the classical no-slip and no penetration boundary conditions on the biocolloid surface
$\partial \mathbb{S}$
. This no-slip condition is consistent with the biocolloid having a hydrophilic surface, where strong fluid–surface interactions prevent tangential slip of the surrounding fluid (Kumar et al. Reference Kumar, Gopmandal, Sinha and Ohshima2019). The boundary conditions on
$\partial \mathbb{S}$
are restated precisely as
Since the surface geometry is slightly deformed from a spherical shape, we use a regular perturbation technique using a small perturbation parameter
$\epsilon$
. Accordingly, the velocity and pressure
$(\boldsymbol{u},p)$
take the following form:
\begin{align} \boldsymbol{u}={\displaystyle \sum _{k=0}^{\infty }\epsilon ^{k}\boldsymbol{u}_{k}}\quad \textrm {and}\quad {p=\displaystyle \sum _{k=0}^{\infty }\epsilon ^{k}p_{k}}, \end{align}
where each pair
$(\boldsymbol{u}_{k},p_k)$
satisfies the Brinkman equation together with the continuity equation. We expand the boundary conditions given by (2.9a
)–(2.10) in a Taylor series in powers of
$\epsilon$
with respect to the undeformed biocolloid surface
$r=a$
with the help of the expression for the unit normal vector. The resulting boundary conditions in the leading and first-order velocities can be written as
where
$\mathbb{I}$
is the identity tensor with
$\boldsymbol{n}_{0}$
and
$\boldsymbol{n}_{1}$
being the leading and the first-order normal vectors, respectively. The far-field conditions for the leading as well as first order can be given in a simplified form as follows:
To determine the velocity and pressure fields in the
$\boldsymbol{U}$
-problem, we adopt the following representation:
and
respectively, which is the complete general solution (Raja Sekhar et al. Reference Raja Sekhar, Padmavathi and Amaranath1997) of (2.8). Here,
$k=0,1$
denote the leading and the first-order terms corresponding to the velocity and pressure, respectively. Note that
$A_k$
and
$B_k$
respectively satisfy
Here, in the absence of any rotation, we set
$B_{k}({r},\theta ,\varphi )=0$
. Therefore, the resulting flow will be expressed in terms of scalars
$A_{k}$
, which can be described as a linear combination of spherical harmonics
$S_n(\theta ,\varphi )$
given by
\begin{align} {A_{k}}=\displaystyle \sum _{n=1}^{\infty }{h_{nk}(r)S_n(\theta ,\varphi )}, \end{align}
where
$h_{nk}$
is the function of radial coordinates given by
and the spherical harmonics are
\begin{align} {S_n(\theta ,\varphi )}=\displaystyle \sum _{m=0}^{n}{P^{m}_{n}\left (\cos \theta \right )}\left ({A_{nm}\cos m\varphi }+{B_{nm}\sin m\varphi }\right )\!. \end{align}
In case the flow generated in the system is axially symmetric and the fluid flow is uniform in the far field, all the quantities are independent of
$\varphi$
. Consequently, all the quantities are independent of
$\varphi$
. Now, the regularity condition as
${r}\to \infty$
forces
${h}_{nk}(r)$
to reduce to
In this situation, the arbitrary constants
$b_{nk}$
and
$d_{nk}$
are determined using the reduced boundary conditions (2.12a
)–(2.12c
), and
$a_{nk}$
is found from the far-field condition given in (2.13) and their explicit expressions are provided in Appendix B. Subsequently, the applied force on the biocolloid due to the hydrodynamic stress can be obtained by evaluating the following integral:
where
$\boldsymbol{\sigma }^{{{U}}}$
is the viscous stress tensor and
${\rm d}S$
is the surface element. This force can be expressed in powers of the perturbation parameter
$\epsilon$
to the first order as
We derive an explicit expression of
$\boldsymbol{F}^{{{U}}}_{k}$
, which is the hydrodynamic force experienced by an undeformed biocolloid, by evaluating the following integral:
where
$\partial \mathbb{S}_{{{U}}}$
represents the surface of undeformed biocolloid and
${\rm d}S_{{{U}}}$
denotes its surface element;
$\boldsymbol{\sigma }^{{{U}}}_{k}$
is the viscous stress tensor, which can be evaluated at each order, once we obtain explicit expressions for
$(\boldsymbol{u}_{k},p_{k})$
from (2.14a
) and (2.14b
). The generic form of
$\boldsymbol{\sigma }^{{{U}}}_{k}$
in the previous integration is given by
where
$p$
is the hydrodynamic pressure, and
$\boldsymbol{\nabla }\boldsymbol{u}_{k}$
and
$ (\boldsymbol{\nabla }\boldsymbol{u}_{k} )^{t}$
are velocity gradient and transpose of velocity gradient in the
$\boldsymbol{U}\text{-problem}$
. To calculate the integral in (2.17c
), we use the Gauss divergence theorem, which provides
where
$V$
is the volume enclosed by the surface of the biocolloid, i.e.
$G(r,a,\theta ,\varphi )=0$
, and a large sphere/deformed sphere with infinite radius concentric to the biocolloid. The first term in (2.17e
) indicates the frictional resistance experienced by the biocolloid as it migrates through the polymer network of the hydrogel medium. In contrast, the second term in (2.17e
) represents the decay of the hydrodynamic force acting on the surface of the biocolloid at far distances. As a result, the applied force on the biocolloid due to hydrodynamic stress is expressed in powers of the perturbation parameter
$\epsilon$
up to the first order, as
where the force components corresponding to the leading order and first order are calculated and obtained as follows:
and
where
$h^{\prime \prime }_{1k}(r)$
(for
$k=0,1$
) denotes the second-order derivative of
$h_{nk}(r)$
as given in (2.16) corresponding to
$n=1$
. Thus, the total hydrodynamic force can be written as
2.2.
$\boldsymbol{E}$
-problem
In the
$\boldsymbol{E}$
-problem, the biocolloid is held stationary
$(\boldsymbol{U}=\boldsymbol{0})$
while subjected to an external weak electric field
$\boldsymbol{E}$
. Consequently, electro-osmotic flow develops, and the combined effect of the external field and electro-osmosis significantly affects the system behaviour, the stability of the equilibrium potential and the hydrodynamic pressure. As electro-osmosis is initiated, fluid motion can generate pressure gradients within the system, leading to pressure variations across regions. For a schematic illustration of the problem addressed in this study, refer to figure 1. The applied electric field
$\boldsymbol{E}$
is directed along the polar axis
$\boldsymbol{\hat {e}}_{z}$
. In this context, if the major axis of the biocolloid is directed along
$\boldsymbol{\hat {e}}_{z}$
, we may consider the prolate nature of the geometry of the biocolloid. However, when the major axis of the biocolloid aligns with the
$\boldsymbol{x}$
-direction, the oblate nature of the shape of the biocolloid is revealed. The electrostatic potential
$\varPsi$
developed here depends on the biocolloid geometry. According to the general electrokinetic theory of the migration of a charged biocolloid in an electrolyte medium,
$\varPsi$
is decomposed into equilibrium potential
$\varPsi ^{0}$
and perturbed potential
$\varPsi ^{{{P}}}$
(i.e.
$\varPsi =\varPsi ^{0}+\varPsi ^{\!{P}}$
). In the absence of an applied electric field, a charged biocolloid immersed in a charged hydrogel establishes an equilibrium electrostatic potential, denoted by
$\varPsi ^{0}$
. Now, both of these potentials,
$\varPsi ^{0}$
and
$\varPsi ^{{{P}}}$
, must have the following representations similar to those presented in (2.11):
\begin{align} {\varPsi ^{0}=\displaystyle \sum _{i=0}^{\infty }\epsilon ^{i}\varPsi ^{0}_{i}}\quad \textrm {and}\quad {\varPsi ^{\!{P}}=\displaystyle \sum _{i=0}^{\infty }\epsilon ^{i}\varPsi ^{\!{P}}_{i}}. \end{align}
Consequently, (2.5) reduces to
\begin{align} -\varepsilon _{0}\varepsilon _{s}{\nabla} ^{2}\big (\varPsi ^{0}+\varPsi ^{\!{P}}\big) =\rho _{{{{T}}}} \approx \sum _{j=1}^{M+N} z^{{{m}}}_{\!j} e\, n^{{{m}}}_{\!j} +\sum _{j=1}^{M} z^{{{f}}}_{\!j} e\, n^{{{f}}}_{\!j}. \end{align}
Note that for a weakly charged biocolloid with surface zeta potential
$\mid \zeta \mid \lesssim {k_{{{B}}}T}/{e}$
, the perturbations to the ion and charge densities (both mobile and fixed charges associated with hydrogel solvent and polymer skeleton, respectively) can be neglected. Even for a charged biocolloid with a slightly deformed shape, such an assumption is an ideal one. Consequently, we set
$n^{{{m}}}_{\!j} \approx {n^{{{m}}^{0}}_{\!j}}$
,
$n^{{{f}}}_{\!j} \approx {n^{{{f}}^{0}}_{\!j}}$
and
$\rho _{{{{T}}}}\approx \rho ^{0}_{{{{T}}}}$
, but
$p = p^{0} + p^{\!{P}}$
and
$\boldsymbol{u} = \boldsymbol{u}^{0}+\boldsymbol{u}^{\!{P}}$
, where the superscript ‘0’ denotes equilibrium and ‘P’ denotes the respective perturbation state. A similar analogy is used in (2.6)–(2.7). The small perturbation quantities are of the order of
$\boldsymbol{E}$
(that is, linear quantities in
$\boldsymbol{E}$
) and their products, which are higher order in
$\boldsymbol{E}$
, can be ignored. The equilibrium mobile ion density
$n^{{{m}}^{0}}_{\!j}$
follows Boltzmann distribution
$n^{{{m}}^{0}}_{\!j} = n^{{{m}}^\infty }_{\!j}\exp (-{{z^{{{m}}}_{\!j}e{\varPsi ^{0}}}/{(k_{{{B}}}T)}} )$
along with the consideration
$|{\varPsi ^0}|\lt {k_{{{B}}}T}/{e}$
(for low surface potential), which reduces to
\begin{align} n^{{{m}}^{0}}_{\!j}=n^{{{m}}^\infty }_{\!j}\left [1-\left (\frac {z^{{{m}}}_{\!j}e}{k_{{{B}}}T}\right )\varPsi ^{0}\right ]\!, \end{align}
where
$n^{{{m}}^\infty }_{\!j}$
is the bulk concentration of mobile ions, which becomes the equilibrium mobile ion density
$n^{{{m}}^{\infty }}_{\!j}$
due to the inclusion of the biocolloid. Note that
$\left |{\varPsi ^0}\right |\lt {k_{{{B}}}T}/{e}$
implies both
$\left |{\varPsi ^0_{0}}\right |\lt {k_{{{B}}}T}/{e}$
and
$\left |\varPsi ^0_{1}\right |\lt {k_{{{B}}}T}/{e\epsilon }$
simultaneously under consideration of the decomposition in the equilibrium potential
$\varPsi ^{0}$
in (2.21). The first term denotes the spherical biocolloid inclusion with a uniform surface-charge distribution. In contrast, the latter arises from considering a slight deformation of the spherical geometry and a non-uniform surface-charge distribution. Accordingly, the mobile ion density becomes
\begin{align} n^{{{m}}^{0}}_{\!j}=n^{{{m}}^\infty }_{\!j}\left [1-\frac {z^{{{m}}}_{\!j}e}{k_{{{B}}}T}\big(\varPsi ^{0}_{0}+\epsilon \varPsi ^{0}_{1}+\mathcal{O}(\epsilon ^{2})\big )\right ]\!. \end{align}
Since
$n^{0}_{\!j} \to n^{{{m}}^{\infty }}_{\!j}$
far away from the biocolloid, then
$\varPsi ^{0}$
(precisely both
$\varPsi ^{0}_{0}$
and
$\varPsi ^{0}_{1}$
) also becomes zero at a considerable distance from the biocolloid. Introducing (2.23a
) into (2.22), we obtain
\begin{align} -\varepsilon _{0}\varepsilon _{s} {\nabla} ^{2} \big (\varPsi ^{0}+\varPsi ^{\!{P}}\big) &\approx \sum _{j=1}^{M+N} z^{{{m}}}_{\!j} e\, n^{{{m}}^{\infty }}_{\!j} \left [ 1-\left (\frac {z^{{{m}}}_{\!j} e}{k_{{{B}}}T}\right )\varPsi ^{0} \right ] + \sum _{j=1}^{M} z^{{{f}}}_{\!j} e\, n^{{{f}}^{0}}_{\!j} \notag \\ &= \sum _{j=1}^{M+N} z^{{{m}}}_{\!j} e\, n^{{{m}}^{\infty }}_{\!j} - \sum _{j=1}^{M+N} \frac {\big (z^{{{m}}}_{\!j}\big )^{2} e^{2} n^{{{m}}^{\infty }}_{\!j}}{k_{{{B}}}T} \,\varPsi ^{0} \notag \\ &\quad + \sum _{j=1}^{M} z^{{{f}}}_{\!j} e\, n^{{{m}}^{\infty }}_{\!j} \left [ 1-\left (\frac {z^{{{m}}}_{\!j} e}{k_{{{B}}}T}\right )\varPsi ^{0} \right ] \frac {n^{{{f}}^{0}}_{\!j}}{n^{{{m}}^{0}}_{\!j}} \notag \\ &= \sum _{j=1}^{M+N} z^{{{m}}}_{\!j} e\, n^{{{m}}^{\infty }}_{\!j} + \sum _{j=1}^{M} z^{{{f}}}_{\!j} e\, n^{{{f}}^{0}}_{\!j} \notag \\ &\quad - \sum _{j=1}^{M+N} \frac {\big (z^{{{m}}}_{\!j}\big )^{2} e^{2} n^{{{m}}^{\infty }}_{\!j}}{k_{{{B}}}T} \,\varPsi ^{0} - \sum _{j=1}^{M} \frac {z^{{{m}}}_{\!j} z^{{{f}}}_{\!j} e^{2} n^{{{f}}^{0}}_{\!j}}{k_{{{B}}}T} \,\varPsi ^{0}. \end{align}
The sum of the first two terms on the right-hand side of (2.24) becomes zero due to the bulk electroneutrality (Mohammadi & Hill Reference Mohammadi and Hill2010; Hill Reference Hill2022) and consequently, following from (2.24), the equilibrium potential
$\varPsi ^{0}$
satisfies
\begin{align} {{\nabla} ^2}{\varPsi ^0}=\frac {2e^{2}}{\varepsilon _0\varepsilon _{s}k_{{{B}}}T}\left [\sum ^{M+N}_{j=1}\frac {1}{2}\big(z^{{{m}}}_{\!j}\big)^{2}n^{{{m}}^{\infty }}_{\!j}+\frac {1}{2}\sum ^{M}_{j=1}z^{{{m}}}_{\!j} z^{{{f}}}_{\!j}n^{{{f}}^{0}}_{\!j}\right ]\varPsi ^{0}, \end{align}
which is the Helmholtz equation for the equilibrium electrostatic potential and can be rewritten as
where
$\kappa$
is the inverse of the Debye screening length, and can be defined in terms of ionic strengths
$I$
and
$I^{{{f}}}$
as follows:
where
$I$
and
$I^{{{f}}}$
can be expressed in the form
$I=1/2\sum \nolimits_{j=1}^{M+N} (z^{{{m}}}_{\!j} )^{2}n^{{{m}}^{\infty }}_{\!j}$
and
$I^{{{f}}}=1/2\sum \nolimits_{j=1}^{M}z^{{{m}}}_{\!j} z^{{{f}}}_{\!j}n^{{{f}}^{0}}_{\!j}$
. It is important to note that
$I$
denotes the bulk ionic strength arising from the fixed charges attached to the polymeric gel matrix (gel counterions) as well as the added salt, with
$n^{{{m}}^\infty }_{\!j}$
representing the bulk ionic concentration. However,
$I^{{{f}}}$
is the ionic strength due to the gel counterions only. We further express
$\kappa ^{-1}$
as
where
$\kappa _{s}=\sqrt { ({2e^{2}I}/{\varepsilon _{0}\varepsilon _{s}k_{{{B}}}T} )}$
is the inverse Debye length based on the ionic strength of the added salt. During the physicochemical interactions between the non-uniform surface charge of the biocolloid and the electrolyte-saturated polymer gel, ions redistribute around the biocolloid, creating an ion cloud. This process ultimately forms a diffuse layer of oppositely charged ions in the liquid surrounding the biocolloid, commonly referred to as the diffuse double layer. The movement of these ions causes the surrounding fluid to flow, which, in turn, results in the movement of the biocolloid. Importantly, the ionic cloud remains nearly spherically symmetric, and the electric field strength and zeta potential (
$\le 25$
mV) are subsequently small enough to deviate the ion cloud (Masliyah & Bhattacharjee Reference Masliyah and Bhattacharjee2006). Furthermore, no additional space charge is generated in the perturbed problem. Therefore, the Debye-layer distortion effect is negligible and this is consistent with the linearised Poisson–Boltzmann framework. The shear plane of the electric double layer is assumed to coincide with the surface
$\partial \mathbb{S}$
of the biocolloid (Masliyah & Bhattacharjee Reference Masliyah and Bhattacharjee2006), as described by (2.2a
). When there is no applied electric field, i.e.
$\boldsymbol{E}=\boldsymbol{0}$
, and the fluid is at rest, i.e.
$\boldsymbol{u}^0=\boldsymbol{0}$
, then the equilibrium potential satisfies the following equation:
which is obtained from (2.7). Equation (2.26) contains the equilibrium potential
$\varPsi ^0$
that satisfies
on the surface
$ (\partial \mathbb{S} )$
of the biocolloid. In addition,
$\varPsi ^0$
becomes zero at a far field from the surface of the biocolloid. In this context, (2.27) suggests an ionic imbalance across the surface
$\varGamma$
that leads to the accumulation of counterions from the added salts,
$\varepsilon _{p}$
is the dielectric constant of the biocolloid and
$\sigma$
is the surface charge density as expressed in (2.4). Note that the non-uniform part of the surface charge density
$\sigma '$
of the surface charge density
$\sigma$
has the form
\begin{align} \sigma '=\sum ^{\infty }_{i=1}\epsilon ^{i}\sigma _{i}g_{i}(\theta ,\varphi ), \end{align}
due to the slightly deformed structure of the charged biocolloid. In the present framework, the prescribed surface charge density
$\sigma$
does not vary due to charge-regulated ion-adsorption. Non-uniformity in surface charge is therefore attributed primarily to geometric effects, such as local surface curvature. Under weak electric-field assumptions and low surface potentials, the electrolyte remains electro-neutral in the bulk, i.e. ion-density perturbations do not contribute to the net charge density. As follows from (2.24) and (2.25b
), the perturbed electrostatic potential
$\varPsi ^{\!{P}}$
satisfies
which is valid within the hydrogel medium and the biocolloid interior, whereas the velocity of the electrolytic fluid
$(\boldsymbol{u}^{\!{P}})$
and the hydrodynamic pressure
$ ({p}^{\!{P}} )$
in the perturbed state conform to the mass and momentum balance governing equations in (2.8). Consequently,
moreover,
$\boldsymbol{u}^{\!{P}}$
satisfies (2.10) (zero penetration and no slip conditions) on the biocolloid surface, accordingly
holds on
$\partial \mathbb{S}$
. Here, the influence of the applied electric field
$\boldsymbol{E}$
is such that
to generate a uniform far-field flow
where
$\boldsymbol{U}_{\infty }=-\rho _{\!f}\ell ^2{\boldsymbol{E}}/{\eta }$
is the undisturbed electroosmotic flow velocity.
The applied electric field does not modify the surface charge density
$\sigma$
given in (2.4) as charge regulation due to ionic adsorption is not assumed on the biocolloid surface. Variation in surface charge density on biocolloids often arises from surface-active agents and impurities. These substances are typically adsorbed at the interface and their molecules can ionise, resulting in a net surface charge. Consequently, this leads to a change in the boundary condition as well. However, a modification of surface charge density due to ionic adsorption is more appropriate for multivalent ions (Jia et al. Reference Jia, Choi, Lee, Soper and Park2022). Therefore, to be consistent with the linearised Poisson–Boltzmann framework for a weakly charged biocolloid in a low electric field strength, the applied potential across the surface of the biocolloid meets both continuity and flux continuity requirements:
along with regularity of
$\varPsi ^{\!{P}}$
at the biocolloid centre. The leading order solutions define a complete electrokinetic solution for a charged sphere in the charged hydrogel. We apply the respective perturbation expansions presented in (2.21) to the governing equations for the induced potential in (2.25b
) and the applied potential in (2.29a
). This yields the following leading and first-order equations satisfied by induced and applied potentials, respectively
The general solutions of (2.30a ) and (2.30b ) are given by
\begin{align} \varPsi ^0_k = {\beta _{00}}k_0(\kappa r) P_0(\cos \theta ) + \sum _{n=1}^{\infty } \chi _{nk}(r) \tilde {M}_n(\theta ,\varphi ) \end{align}
and
\begin{align} {\varPsi ^{\!{P}}_{k}}=\displaystyle \sum _{n=1}^{\infty }{\omega _{nk}(r)\tilde {N}_n(\theta ,\varphi )} \quad \text{for all } \ n \ge 1, \end{align}
where
$\chi _{nk}$
and
$\omega _{nk}$
are the functions of radial coordinates given by
and
where
$i_n$
and
$k_n$
are the modified spherical Bessel functions of first and second kind, respectively. Furthermore, the presence of radial function
$k_0(\kappa r)$
in (2.31a
) corresponds to a spherically symmetric equilibrium potential. The equilibrium potential
${\varPsi ^{0}_{k}}\to 0$
as
$r\to \infty$
implies that (2.31c
) reduces to
and
$\beta _{00}$
,
${\beta }_{nk}$
,
$\tilde {\beta }_{nk}$
are subsequently obtained from (2.27) and (2.29f
), and the far-field condition given in (2.29d
) determines the value of
$\tilde {\alpha }_{nk}$
and is explicitly presented in Appendix A. The spherical harmonics
$\tilde {M}_n(\theta ,\varphi )$
and
$\tilde {N}_n(\theta ,\varphi )$
are defined as
\begin{align} {\tilde {M}_n(\theta ,\varphi )}=\displaystyle \sum ^{n}_{m=0}{P^{m}_{n}(\cos (\theta ))}({\tilde {C}_{nm}\cos (m\varphi )}+{\tilde {D}_{nm}\sin m\varphi }) \end{align}
and
\begin{align} {\tilde {N}_n(\theta ,\varphi )}=\displaystyle \sum ^{n}_{m=0}{P^{m}_{n}(\cos (\theta ))}({\tilde {E}_{nm}\cos (m\varphi )}+{\tilde {F}_{nm}\sin m\varphi }). \end{align}
Note that the present study considers the Debye layer thickness described by (2.25c ) free from the parameter responsible for a small deformation in the biocolloid geometry. Basically, Debye layer formation depends on the ionic strengths as suggested by (2.25d ). The expansion corresponding to the equilibrium potential is deployed within the boundary condition given by (2.27) to obtain the following forms corresponding to the leading and first orders, respectively as follows:
and
$\mathcal{O}(\epsilon ):\quad$
\begin{eqnarray} \varepsilon _{0}\varepsilon _{s} \boldsymbol{\nabla } \varPsi ^{0}_0 \big|_{\textit{out}} \boldsymbol{\cdot }\boldsymbol{n_1} - \varepsilon _{0}\varepsilon _{p} \boldsymbol{\nabla } \varPsi ^{0}_0 \big|_{\textit{in}} \boldsymbol{\cdot }\boldsymbol{n_1} &+& \varepsilon _{0}\varepsilon _{s} \boldsymbol{\nabla } \left(\varPsi ^{0}_1\big|_{\textit{out}} + g_1 \frac {\partial \varPsi ^{0}_0\big|_{\textit{out}}}{\partial r}\right) \boldsymbol{\cdot }\boldsymbol{n_0} \\ \nonumber &-& \varepsilon _{0}\varepsilon _{p} \boldsymbol{\nabla } \left(\varPsi ^{0}_1\big|_{\textit{in}} + g_1 \frac {\partial \varPsi ^{0}_0\big|_{\textit{in}}}{\partial r}\right) \boldsymbol{\cdot }\boldsymbol{n_0} = -\sigma _1 g_1(\theta ,\varphi ). \end{eqnarray}
Similarly, we deploy the series expansion in (2.21) corresponding to the perturbed potential into the boundary condition (2.29f ) to obtain
and
\begin{eqnarray} \varepsilon _{0}\varepsilon _{s} \boldsymbol{\nabla } \left (\varPsi ^{\!{P}}_1\big|_{\textit{out}} + g_1 \frac {\partial \varPsi ^{\!{P}}_0\big|_{\textit{out}}}{\partial r}\right ) \boldsymbol{\cdot }\boldsymbol{n}_0 &-& \varepsilon _{0}\varepsilon _{p} \boldsymbol{\nabla } \left (\varPsi ^{\!{P}}_1\big|_{\textit{in}} + g_1 \frac {\partial \varPsi ^{\!{P}}_0\big|_{\textit{in}}}{\partial r}\right ) \boldsymbol{\cdot }\boldsymbol{n}_0\\ \nonumber &+& \varepsilon _{0}\varepsilon _{s} \boldsymbol{\nabla } \varPsi ^{\!{P}}_0\big |_{\textit{out}} \boldsymbol{\cdot }\boldsymbol{n_1} -\varepsilon _{0}\varepsilon _{p} \boldsymbol{\nabla } \varPsi ^{\!{P}}_0\big|_{\textit{in}} \boldsymbol{\cdot }\boldsymbol{n_1} = 0, \end{eqnarray}
which are the conditions on the leading and first-order terms of the perturbed potential, respectively. A similar attempt on the boundary conditions over the velocity fields would result in simplified boundary conditions in leading and first order, respectively as follows:
Note that the first and third conditions here pertain to the normal and tangential velocities at the leading order (denoted as
$\mathcal{O} (\epsilon ^{0} )$
). In contrast, the second and fourth conditions relate to those in the first order (denoted as
$\mathcal{O} (\epsilon ^{1} )$
). Leading order velocities are also involved in the second and fourth conditions. The leading and first-order velocities satisfy the following simplified form of far-field condition obtained from (2.29e
), which are
Similar to the
$\boldsymbol{U}$
-problem, the velocity field corresponding to the
$\boldsymbol{E}$
-problem adopts the representation
where for each
$k=0,1$
,
${\tilde {A}}_{k}$
and
${\tilde {B}}_{k}$
satisfy
respectively. Similar to the
$\boldsymbol{U}$
-problem, in the absence of any rotation in the
$\boldsymbol{E}$
-problem, we set
${{\tilde {B}}_{k}({r},\theta ,\varphi )}=0$
. Therefore, the resulting flow fields expressed in terms of scalars
${\tilde {A}}_{k}$
can be presented as a combination of spherical harmonics in the following manner:
\begin{align} {{\tilde {A}}_{k}}=\displaystyle \sum _{n=1}^{\infty }{\tilde {h}_{nk}(r)\tilde {S}_n(\theta ,\varphi )}, \end{align}
where
$\tilde {h}_{nk}$
is the functions of radial coordinates given by
in a similar manner as in (2.15b
). However, the spherical harmonic
$\tilde {S}_n(\theta ,\varphi )$
are expressed similarly to (2.15c
) in a respective manner as
\begin{align} {\tilde {S}_n(\theta ,\varphi )}=\displaystyle \sum _{m=0}^{n}{P^{m}_{n}(\cos (\theta ))}({\tilde {C}_{nm}\cos (m\varphi )}+{\tilde {D}_{nm}\sin (m\varphi )}), \end{align}
where
$\tilde {C}_{nm}$
and
$\tilde {D}_{nm}$
are the arbitrary constants. Note that, like the
$\boldsymbol{U}$
-problem, in the
$\boldsymbol{E}$
-problem, the generation of axially symmetric flow induces a uniform velocity at the far field. Consequently, all the quantities are independent of
$\varphi$
. Now, the regularity condition as
${r}\to \infty$
forces
$\tilde {h}_{nk}(r)$
to reduce into
where
$F_{nk}$
is the particular integral of (2.40d
), explicitly given in Appendix C, and
$\tilde {b}_{nk}$
,
$\tilde {d}_{nk}$
are determined using the given boundary conditions of the system (2.36a
)–(2.36d
) and
$\tilde {a}_{nk}$
is given by the far-field condition (2.37), with explicit expressions provided in Appendix C. Knowing
${\tilde {A}}_{k}$
, the velocity components can be computed for the system using
\begin{align} {u}^{\!{P}}_{r}=-{{\frac {1}{r}}\left (\frac {\partial ^2{{\tilde {A}}_{k}}}{\partial {\theta ^2}}+\cot \theta \frac {\partial {{\tilde {A}}_{k}}}{\partial {\theta }}\right )} \end{align}
and
\begin{align} {u}^{\!{P}}_{\theta }=-{{\frac {1}{r}}{\frac {\partial }{\partial {\theta }}}\left ({\tilde {A}}_{k}+r\frac {\partial {{\tilde {A}}_{k}}}{\partial {r}}\right )}. \end{align}
Now, we substitute
${\tilde {A}}_{k}$
from (2.40a
) into (2.40a
)–(2.40d
) to obtain
\begin{align} {u}^{\!{P}}_{k,r}=\displaystyle \sum _{n=1}^{\infty }\frac {2}{r}\tilde {h}_{nk}(r)\tilde {S}_n(\theta ,\varphi ) \end{align}
and
\begin{align} {u}^{\!{P}}_{k,\theta }=\displaystyle \sum _{n=1}^{\infty }\frac {1}{r}\frac {\partial }{\partial r} \big(r\tilde {h}_{nk}(r)\big)\frac {\partial {\tilde {S}_n}}{\partial {\theta }}, \end{align}
respectively, when
$k=0,1$
. These velocity fields can further be used to compute stresses on the biocolloid.
In the
$\boldsymbol{E}$
-problem, the biocolloid migrates under the influence of an external electric field. The applied force on the biocolloid contributes to electrostatic and hydrodynamical stresses. Under the action of an applied electric field, the following electrostatic force is developed on it:
where
is the Maxwell electrical stress tensor (Choudhary et al. Reference Choudhary, Renganathan and Pushpavanam2019). Now, corresponding to the leading and first order, the electrical forces are
\begin{align} \boldsymbol{F}^{{{\textit{ES}}}}_{0}&= \left [\oint _{\partial \mathbb{S}_{{{U}}}} \varepsilon _0\varepsilon _s \left ( -\frac {\partial \varPsi _{0}}{\partial r} \frac {\partial \varPsi _{0}}{\partial \theta } \sin \theta -\left (\frac {1}{r}\frac {\partial \varPsi _{0}}{\partial \theta }\right )^2 \cos \theta \right ) a^2 \sin \theta \, {\rm d}\theta \, {\rm d}\varphi \right ]\boldsymbol{E} \end{align}
and
\begin{align} \boldsymbol{F}^{{{\textit{ES}}}}_{1} &= \Bigg [ \varepsilon _0\varepsilon _s \oint _{\partial \mathbb{S}_{{{U}}}} \Bigg ( -\frac {2}{r}\frac {\partial g_{1}}{\partial \theta } \frac {\partial \varPsi _{0}}{\partial r} \frac {\partial \varPsi _{0}}{\partial \theta }\cos \theta \nonumber\\ &\quad + \Bigg ( \frac {1}{r} \left ( \frac {\partial \varPsi _{0}}{\partial r}\frac {\partial \varPsi _{1}}{\partial \theta } + \frac {\partial \varPsi _{1}}{\partial r}\frac {\partial \varPsi _{0}}{\partial \theta } \right ) + \frac {\partial g_{1}}{\partial \theta } \left (\frac {\partial \varPsi _{0}}{\partial r}\right )^2 \Bigg ) \sin \theta \Bigg ) \nonumber\\ &\quad \times a^2 \sin \theta \, {\rm d}\theta \, {\rm d}\phi \Bigg ] \boldsymbol{E}. \end{align}
respectively. Note that in the above-mentioned two forces,
$\varPsi _{0}=\varPsi ^{0}_{0}+\varPsi ^{\!{P}}_{0}$
and
$\varPsi _{1}=\varPsi ^{0}_{1}+\varPsi ^{\!{P}}_{1}$
. However, to calculate the hydrodynamic force on the biocolloid by the surrounding medium, it is customary to integrate stress tensor over the surface of the biocolloid, which is
where
$\boldsymbol{\sigma }^{{{\textit{EH}}}}_{k}$
in the previous integration takes the form of the incompressible fluid that saturates the hydrogel medium surrounding the biocolloid. Accordingly,
where
$p^{{{\textit{EH}}}}_k$
is the pressure in the
$\boldsymbol{E}$
-problem, and
$\boldsymbol{\nabla }\boldsymbol{u}^{\!{P}}_{k}$
and
$ (\boldsymbol{\nabla }\boldsymbol{u}^{\!{P}}_{k} )^{t}$
are the velocity gradient and transpose of velocity gradient in the
$\boldsymbol{E}$
-problem. To calculate the integral in (2.43), the divergence theorem is applied, which is followed by the use of (2.45) to obtain
where, unlike the
$\boldsymbol{U}$
-problem, in the
$\boldsymbol{E}$
-problem, the biocolloid experiences both the frictional drag force from the hydrogel medium, along with the electrostatic body force due to the mobile charges in the surrounding hydrogel medium. The axisymmetric nature of our problem suggests that only the axial component of these forces needs to be considered. Within the hydrogel medium, the biocolloid undergoes translational motion under the external electric field parallel to the major axis. The electro-hydrodynamic forces acting on the biocolloid, calculated up to the first order of
$\epsilon$
, are given by
where
and
where
\begin{eqnarray} p^{{{\textit{EH}}}}_1(a) &=& \eta a\bigg ( \tilde {h}'''_{11}(a) + 3\frac {\tilde {h}''_{11}(a)}{a} - \tilde {h}'_{11}(a) \left (\frac {2}{a^2} + \frac {1}{\ell ^{2}}\right ) + \tilde {h}_{11}(a) \left (\frac {2}{a^3} - \frac {1}{a\ell ^{2}} \right ) \bigg ) \nonumber \\ && + \sigma _0 \bigg ( (1+\gamma ) \frac {\kappa ^2 a^2}{(\kappa a+1)} \big(\kappa ^2 a^2 + 2\kappa a + 2 + \sigma _1\big) - \frac {2\kappa ^2 a^2}{15} \left (\frac {\kappa ^2 a^2 + 3\kappa a + 3}{\kappa ^3 a^3 + 4\kappa ^2 a^2 + 9\kappa a + 9} \right ) \nonumber \\ && + \frac {18}{5(\lambda +2)} \big(\kappa ^2 a^2 + a\rho _{\!f}\big) \bigg ) \end{eqnarray}
and
\begin{eqnarray} p^{{{\textit{EH}}}}_0(a) &=& \eta a\bigg (\tilde {h}'''_{10}(a) + 3\frac {\tilde {h}''_{10}(a)}{a} - \tilde {h}'_{10}(a) \left (\frac {2}{a^2} + \ell ^{-2} \right ) + \tilde {h}_{10}(a) \left (\frac {2}{a^3} - \frac {1}{a\ell ^{2}} \right ) \bigg ) \nonumber \\[3pt] && + \frac {\kappa ^2 a^2 \sigma _0}{(\kappa a+1)} (1+\gamma ) + a \rho _{\!f} (1+\gamma ). \end{eqnarray}
2.3. Electrophoretic mobility
$\mu _{{{E}}}$
calculation
The total force in the
$\boldsymbol{E}$
-problem is obtained by adding the electrostatic and electro-hydrodynamic forces as stated:
where
The leading order forces are derived from (2.45a
) and (2.53a
), while the first-order forces are calculated using (2.45b
) and (2.53b
). However, in the
$\boldsymbol{U}$
-problem, the only force acting on the biocolloid is a purely hydrodynamic in nature:
where
The leading and first-order forces are calculated from (2.19a
) and (2.19b
), respectively. Hence, the total force on the biocolloid is the sum of the forces
$\boldsymbol{F}^{{{E}}}$
and
$\boldsymbol{F}^{{{U}}}$
obtained from the
$\boldsymbol{E}$
- and
$\boldsymbol{U}$
-problem, respectively. At the steady state, this net force on the biocolloid must be zero, i.e.
Accordingly, the electrophoretic mobility for a slightly deformed biocolloid is obtained as
\begin{align} \mu _{{{E}}} = \frac {F^{{{\textit{ES}}}} + F^{{{\textit{EH}}}}}{F^{{{U}}}} = \frac {\left (F^{{{\textit{ES}}}}_{0} + F^{{{\textit{EH}}}}_{0}\right ) + \epsilon \left (F^{{{\textit{ES}}}}_{1} + F^{{{\textit{EH}}}}_{1}\right )} {\left (F^{{{U}}}_{0} + \epsilon F^{{{U}}}_{1}\right )}. \end{align}
The mobility expression here is lengthy and cumbersome, as it involves several mathematical special functions. Therefore, it is convenient to derive various limiting cases of electrophoretic mobility corresponding to an undeformed biocolloid (
$\epsilon =0$
).
2.4. Various limiting cases for spherical biocolloid
-
(i) General mobility expression for spherical biocolloid.
The mobility expression for a spherical biocolloid (with
$\epsilon =0$
) from (2.55) can be given in an explicit form:
\begin{align} \mu _{{{E}}}=\;& \frac {2\sigma _0a}{3\eta \left (\frac {a^2}{3\ell ^2}+\frac {a}{\ell }+1\right )} \bigg \{ \frac {1}{6\left (\frac {a}{\ell }\right )^2(\kappa a+1)} \bigg [ 2\left (\frac {a}{\ell }\right )(\kappa a)^2 +8\left (\frac {a}{\ell }\right )^2(\kappa a) +6\left (\frac {a}{\ell }\right )^3(\kappa a) +6\left (\frac {a}{\ell }\right )^2 \nonumber \\[3pt] &\qquad +4\left (\frac {a}{\ell }\right )^2(\kappa a)^2 +2\left (\frac {a}{\ell }\right )^3(\kappa a)^2 +3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^2 +3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^3 \bigg ] \nonumber \\[3pt] &+\frac {1}{6\left (\frac {a}{\ell }\right )^2(\kappa a+1)} \bigg ( 2(\kappa a)^3 -2\left (\frac {a}{\ell }\right )(\kappa a)^2 -2\left (\frac {a}{\ell }\right )^3\gamma (\kappa a)^3 +2\left (\frac {a}{\ell }\right )^4\gamma (\kappa a)^2 \bigg ) \nonumber \\[3pt] &\qquad \times \exp \!\left [\kappa a\!\left (1+\frac {\ell }{a}\right )\right ] E_1\!\left [\kappa a\!\left (1+\frac {\ell }{a}\right )\right ] \nonumber \\[3pt] &+\frac {1}{6\left (\frac {a}{\ell }\right )^2(\kappa a+1)} \bigg ( 3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^4 -2\left (\frac {a}{\ell }\right )^4\gamma (\kappa a)^2 \bigg )\exp (\kappa a)E_1(\kappa a) \nonumber \\[3pt] &-\frac {\left (\frac {a^2}{3\ell ^2}+\frac {a}{\ell }+1\right )} {18\left (\frac {a}{\ell }\right )(\kappa a+1)} \bigg ( 3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^2 +3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^3 -6\left (\frac {a}{\ell }\right )^3\gamma (\kappa a)^2 \nonumber \\[3pt] &\qquad -2\left (\frac {a}{\ell }\right )\gamma (\kappa a)^2 -2\left (\frac {a}{\ell }\right )\gamma (\kappa a)^3 +2\left (\frac {a}{\ell }\right )\gamma (\kappa a)^4 \bigg ) \nonumber \\[3pt] &-\frac {\left (\frac {a^2}{3\ell ^2}+\frac {a}{\ell }+1\right )} {18\left (\frac {a}{\ell }\right )(\kappa a+1)} \big ( 6(\kappa a)^3 -6\left (\frac {a}{\ell }\right )(\kappa a)^2 -6\left (\frac {a}{\ell }\right )^3\gamma (\kappa a)^3 \nonumber \\[3pt] &\qquad +6\left (\frac {a}{\ell }\right )^4\gamma (\kappa a)^2 \bigg ) \nonumber \\[3pt] &\qquad \times \exp \!\left [\kappa a\!\left (1+\frac {\ell }{a}\right )\right ] E_1\!\left [\kappa a\!\left (1+\frac {\ell }{a}\right )\right ] \nonumber \\[3pt] &-\frac {\left (\frac {a^2}{3\ell ^2}+\frac {a}{\ell }+1\right )} {18\left (\frac {a}{\ell }\right )(\kappa a+1)} \bigg ( 6\left (\frac {a}{\ell }\right )(\kappa a)^2 +3\left (\frac {a}{\ell }\right )^2\gamma (\kappa a)^4 \nonumber \\[3pt] &\qquad -6\left (\frac {a}{\ell }\right )^4\gamma (\kappa a)^2 +2\left (\frac {a}{\ell }\right )\gamma (\kappa a)^5 \bigg )\exp (\kappa a)E_1(\kappa a) \nonumber \\[3pt] &+ \left (\frac {3}{2}\frac {\rho _f a}{\sigma _0}\right )\left (\frac {\ell }{a}\right )^2 \left (\kappa a\right ) \bigg ( \frac {1}{3}\left (\frac {a}{\ell }\right )^2 +\left (\frac {a}{\ell }\right ) +1 \bigg ) \bigg \}, \end{align}
where the exponential integral
$E_1(x)$
is defined as
and
$\gamma ={(\varepsilon _s-\varepsilon _p)}/{(\varepsilon _p+2\varepsilon _s)}$
. Note that the mobility expression for a spherical biocolloid given by (2.56) corresponds to a fixed baseline uniform surface charge density
$\sigma _0$
(owing to the assumption (2.4)) and a finite range of scaled Debye screening length. To demonstrate the physical consistency of the mobility expression in (2.56), three classical limiting cases, free-fluid Stokes limit, the high-resistance Darcy Limit, and thin Debye layer Smoluchowski limit and Huckel mobility (
$\kappa a\ll 1$
), are derived.
-
(ii) Free-fluid Stokes limit for spherical biocolloid. For a spherical biocolloid, the Stokes limit is obtained when the Brinkman screening length (
$\ell$
) is much larger than the biocolloid radius. Physically, this corresponds to negligible resistance
$ ( a/\ell \to 0 )$
in the hydrogel medium. In the Stokes limit, the mobility expression for a spherical biocolloid in a charged gel
$(\rho _{\!f}\ne 0)$
is given by
where
\begin{align} \begin{aligned} f\left (\kappa a,\gamma , \rho _fa/\sigma _0\right ) = \Bigg [ & \frac {2(\kappa a)^2}{3} + \frac {(\kappa a)^2}{3}(1-2\gamma ) \\ &+ \frac {(\kappa a)^2}{3} \big ( 3\gamma (\kappa a)^2 -2\gamma \big ) \exp (\kappa a)E_1(\kappa a) \\ &+ \left (\frac {3}{2}\frac {\rho _fa}{\sigma _0}\right ) \left(\frac {\ell }{a}\right)^2 \left (1+\frac {1}{\kappa a}\right ) \Bigg ] \end{aligned} \end{align}
contains the explicit contribution of the scaled Debye screening length
$\kappa a$
,
$\gamma$
and
$\rho _fa/\sigma _0$
. Physically, the appearance of the exponential integral reflects the finite thickness of the ionic double layer and the gradual decay of the electrostatic disturbance into the bulk electrolyte. When combined with the Stokes limit, the electro-hydrodynamic mobility is governed entirely by viscous shear stresses and the electric body force in the diffuse layer. However, the last term containing
$(\ell /a)^2$
in
$f(\kappa a,\gamma ,\rho _fa/\sigma _0,)$
formally diverges in the Stokes limit (
$a/\ell \to 0$
). This divergence is purely a scaling artefact of the chosen far-field electrosmotic flow velocity
$\boldsymbol{U}_{\infty }=-\rho _{\!f}\ell ^2{\boldsymbol{E}}/{\eta }$
; in the limit where the porous resistance vanishes, this term has no contribution. Furthermore, it is worth noting that in uncharged hydrogel (
$\rho _f=0$
), the scaled Debye screening length
$\kappa a=\kappa _sa\,(\text{scaled Debye length due to mobile ions only})$
due to the vanishing ionic strength
$I^{{{f}}}$
given in (2.25d
).
Owing to the much higher permittivity of the surrounding electrolyte compared with that of the biocolloid (i.e.
$\varepsilon _p \ll \varepsilon _s$
which means
$\gamma \approx 0.5$
), the mobility expression in (2.58) for a spherical biocolloid with constant
$\zeta$
potential (
$\zeta ={\sigma _0 a}/{\varepsilon _0 \varepsilon _s (\kappa a + 1)}$
) suspended in an uncharged gel subsequently reduces to
-
(iii) Huckel mobility.Equation (2.60) involves exponential integral function, which for
$\kappa a\ll 1$
further reduces to
where
$\delta$
denotes the Euler–Mascheroni constant. Hence, for
$\kappa a\ll 1$
, the mobility given in (2.60) simplifies to
-
(iv) High resistance Darcy limit for spherical biocolloid. When the Brinkman screening length of the hydrogel medium becomes very small compared with the charged spherical biocolloid radius, i.e.
${a}/{\ell }\rightarrow \infty$
, (2.56) reduces to
The mobility given by (2.63) has a permeability-controlled hydrogel effect proportional to
$\ell ^2$
. The vanishing of the permeability-controlled term in (2.63) for
$a/\ell \to \infty$
correctly reflects the suppression of fluid-mediated transport in a highly resistive porous matrix. For a constant
$\zeta$
potential value (
$\zeta = \sigma _{0}a/\varepsilon _0\varepsilon _s(\kappa a +1)$
), (2.63) reduces to
-
(v) Thin Debye layer Smoluchowski limit. The Smoluchowski limit is obtained by considering the thin double-layer regime (
$\kappa a \gg 1$
). In this limit, the Debye length is much smaller than the biocolloid radius (
$\kappa ^{-1}\ll a$
). The Smoluchowski limit is valid in the Stokes limiting regime (
$a/\ell \to 0$
), assuming the gel is uncharged (
$\rho _{\!f}\to 0$
). For finite
$\kappa a$
, the Debye layer surrounding a uniformly charged spherical biocolloid (
$\epsilon =0$
with fixed
$\sigma _0$
) remains spherically symmetric, but deviates slightly from the planar exponential profile due to geometric dilution of the electrostatic field. Specifically, the spherical solution contains a factor
$a/r$
, which introduces small curvature corrections of order
$\mathcal{O}\! ({1}/{\kappa a} )$
within the Debye layer. Moreover, the electrostatic potential surrounding the spherical biocolloid follows
$\varPsi \sim ({a}/{r})\exp (-\kappa a (r/a-1))$
. Expanding the factor
$a/r$
near the surface with
$\delta =\mathcal{O}(\kappa ^{-1})$
gives
Since
$\delta /a=\mathcal{O}(1/(\kappa a))$
, we obtain
Thus, curvature introduces corrections of order
$\mathcal{O}(1/(\kappa a))$
within the finite range of the Debye layer. These corrections modify the magnitude of the electrostatic stress. In the thin Debye layer Smoluchowski limit (
$\kappa a \to \infty$
), the double layer locally resembles a flat surface. Hence, in
$\kappa a\gg 1, a/\ell \to 0$
, the mobility for spherical biocolloid given in (2.60) reduces to
It is important to note that the Smoluchowski limit is for a constant
$\zeta$
potential. However, the general mobility expression obtained here is for a constant surface charge density
$\sigma _0$
. Therefore, for a constant
$\zeta$
potential in the asymptotic structure, (2.67) reduces to
which is exactly the Smoluchowski mobility given in previous studies (von Smoluchowski Reference von Smoluchowski1903; Ohshima Reference Ohshima2019). Here,
$\zeta$
is obtained from the spherical symmetry part of (2.31a
), which is
$\zeta = \sigma _{0}a/\varepsilon _0\varepsilon _s(\kappa a +1)$
that coincides with that of Li & Hill (Reference Li and Hill2013).
3. Results and discussion
The electrophoresis of a slightly deformed spherical charged biocolloid with a non-uniform surface charge is studied in a charged hydrogel medium. This analysis spans a broad range of electrokinetic parameters, including the scaled Debye length
$(\kappa a)$
, the fixed charge density of the hydrogel
$(\rho _{\!f})$
, the surface charge density of the biocolloid
$(\sigma )$
and the medium permittivity ratio
$(\varepsilon _{{P}}/\varepsilon _s)$
. Additionally, the permeability parameter given by the Brinkman screening length
$(\ell )$
, along with the shape parameter
$(\epsilon )$
, has been considered here.
The parameter ranges are chosen to ensure computational consistency while guiding the appropriate geometric influence and the surrounding microenvironment effects in engineered biocolloid design. In particular, the biocolloid radius is constrained by well-established biological clearance mechanisms. Biocolloids with a diameter of
${\lt} 5.5\,\rm nm$
are rapidly cleared from the bloodstream via renal filtration (Nejati et al. Reference Nejati, Vadeghani, Khorshidi and Karkhaneh2020). In contrast, biocolloids with a diameter
${\gt} 200\,\rm nm$
are efficiently removed from the circulation by the mononuclear phagocyte system, which includes macrophages in the spleen and Kupffer cells in the liver (Choi et al. Reference Choi, Hak, Wenhao, Preeti, Eiichi, John, Ipe, Binil, Moungi and Frangioni2007; Duan & Li Reference Duan and Li2013). Furthermore, organ-specific drug delivery imposes additional geometric constraints. For example, Kim et al. (Reference Kim, Kim, Kim, Kim and Yu2009) described that biocolloids intended for central nervous system therapies must be sufficiently small (approximately
$20\,\rm nm$
) to cross the blood–brain and blood–retinal barriers. Consequently, to ensure that the present analysis remains grounded in realistic biophysical constraints rather than a mere mathematical exercise, the biocolloid diameter is restricted to the physiologically relevant range of
$5.5{-}200\,{\rm nm}$
. In addition to size effects, biocolloid shape plays a crucial role in determining its biodistribution and cytotoxicity. Biocolloids with significantly higher aspect ratios often exhibit increased cytotoxicity, primarily due to reduced clearance efficiency and prolonged circulation time (Fubini et al. Reference Fubini, Fenoglio, Tomatis and Turci2011). Therefore, to address this issue, it is advisable to limit the aspect ratio to a range of
$0.7\lt b/a\lt 1.3$
, as this provides a physiologically relevant design window for drug delivery applications. In related work, Hsu et al. (Reference Hsu, Lin, Yeh and Lin2012) investigated the mobility of poly-electrolyte ellipsoidal biocolloids with aspect ratios
$b/a$
ranging from 0.5 to 2, exceeding the
$b/a$
range adopted here. Consequently, the surface parameter
$\epsilon =1-b/a$
is restricted to
$-0.3\le \epsilon \le 0.3$
. This chosen range represents a conservative and physically realistic regime for a slightly deformed biocolloid, ensuring that the deformation remains small enough to justify the perturbation approach, while also remaining consistent with typical geometric variations observed in biomedical and colloidal constraints.
Biological fluids (blood plasma, interstitial fluid, cerebrospinal fluid, etc.) relevant to drug delivery are electrolytes in nature, containing monovalent ions, primarily
${\rm Na}^+$
,
${\rm Cl}^-$
,
${\rm K}^+$
(Vereninov et al. Reference Vereninov, Yurinskaya, Model and Vereninov2016). Consequently, a hydrogel saturated with a symmetric binary electrolyte provides a physically consistent representation of the ionic environment as encountered in this work. Furthermore, Gull et al. (Reference Gull, Khan, Butt, Khalid, Shafiq, Islam, Asim, Hafeez and Khan2019) reported that at high electrolyte concentrations, polymer solubility decreases, ultimately leading to reduced drug release. Therefore, the choice of ionic strength further supported the experimental and simulation-based data. Within this framework, the ionic strengths
$I$
and
$I^{f}$
in (2.25d
) are reported as
$0.5{-}50\, \text{mM}$
encompassing both dilute to moderately concentrated electrolytes that saturate the hydrogel (Bach et al. Reference Bach, Hollingsworth and Koch2002; Hanauer et al. Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007). When combined with biocolloid radius, the screening lengths correspond to
$\kappa a$
values that range from
$0.01$
to
$10$
. This supports the range used in this study as being physiologically realistic.
In a highly concentrated electrolyte (ionic strength
$I\ge 1$
mol l
$^{-1}$
), ion–ion correlations become significant even for monovalent electrolytes (Sambamoorthy & Chu Reference Sambamoorthy and Chu2025). The situation is even more pronounced for multivalent electrolytes, where finite ion-size effects and strong electrostatic correlations occur even at much lower salt concentrations, owing to enhanced ion–ion interactions and counter-ion condensation near charged surfaces (Semenov et al. Reference Semenov, Raafatnia, Sega, Lobaskin, Holm and Kremer2013; Gopmandal et al. Reference Gopmandal, Bhattacharyya and Barman2014; Mondal & Bhattacharyya Reference Mondal and Bhattacharyya2025). Under such conditions, specific ion adsorption becomes significant, leading to a modification of the effective surface charge density, a phenomenon that is particularly relevant for multivalent ions (Jia et al. Reference Jia, Choi, Lee, Soper and Park2022). Moreover, elevated surface charge density enhances non-specific binding of serum proteins and subsequent macrophage uptake. Also, it promotes rapid recognition and clearance by mononuclear phagocytes, such as RAW
$264.7$
cells, resulting in a shorter systemic circulation time (Xiao et al. Reference Xiao, Li, Luo, Lee, Xiao, Gonik, Agarwal and Lam2011). To avoid unrealistically strong immune clearance, the biocolloid surface charge density is therefore considered as weakly charged, ranging from
$-0.175\,{\unicode{x03BC}} \text{C}\,\text{m}^{-2}$
to
$- 0.8\,{\unicode{x03BC}} \text{C}\,\text{m}^{-2}$
. Accordingly, the surface charge density
$\sigma$
is composed of a uniform baseline value
$\sigma _0$
and a deviation
$\sigma _1$
that arises from slight deformations of the biocolloid from the ideal spherical shape. Following Li & Hill (Reference Li and Hill2013), the uniform surface charge density
$\sigma _0$
is taken to be
$-0.5\,{\unicode{x03BC}} \text{C}\,\text{m}^{-2}$
, while the ratio
$\sigma _1/\sigma _0$
is assumed to lie within the range
$(0.01,\,10)$
. This present model is based on the assumption that the surface potential is very low, i.e.
$|{\varPsi ^0}|\lt {k_{{{B}}}T}/{e}$
, which is equal to the
$\zeta$
potential at the biocolloid surface, yielding an approximate value
$|{\zeta }|\le 25$
mV.
Due to the non-spherical geometry, the biocolloid surface accumulates a non-uniform surface charge, giving rise to an electrostatic force. Simultaneously, hydrodynamic drag results from the fluid flow past the slightly deformed biocolloid. Together, these electrostatic and hydrodynamic forces drive the steady migration of the charged biocolloid through the gel medium. We perform the analysis over a broad range of the aforementioned parameters. In this context, the dielectric permittivity ratio,
$\lambda =\varepsilon _{{P}}/\varepsilon _s$
, is calculated by considering
$\varepsilon _{{P}}$
for biocolloids and
$\varepsilon _s$
for various hydrogels. The dielectric constant of charged biocolloids, such as proteins or DNA, typically ranges from
$4\,{\rm to }\,20$
C Vm−1, with a common value of approximately
$4$
C Vm−1. Larger dielectric constants, including values like
$8$
,
$10$
,
$11$
and
$20$
C Vm−1, have also been reported (Li et al. Reference Li, Li, Zhang and Alexov2013). However, the dielectric constant of hydrogels can vary significantly based on their composition and water content (Naderi-Boldaji et al. Reference Naderi-Boldaji, Fazeliyan-Dehkordi, Mireei and Ghasemi-Varnamkhasti2015). For example, in agarose hydrogels,
$\varepsilon _s$
is typically reported to be
$6.79$
. However, various hydrogel systems have exhibited dielectric constants ranging from
$20$
to
$82$
(Naderi-Boldaji et al. Reference Naderi-Boldaji, Fazeliyan-Dehkordi, Mireei and Ghasemi-Varnamkhasti2015). Consequently, to account for a wide variety of biocolloids and hydrogel systems, we have chosen the
$\lambda$
within the range
$0\lt \lambda \lt 10$
.
A cross-linked polymeric network in a hydrogel contains interconnected open spaces, in which the pore-scale structure is incorporated through the effective permeability
$k$
, where
$\ell =\sqrt {k}$
. The microstructure of a polymer gel may be characterised in terms of the polymer volume fraction
$\phi _p$
, with the porosity (or void fraction) defined as
As the polymer volume fraction increases, the available pore space for fluid flow decreases, leading to increased tortuosity of flow paths and enhanced hydrodynamic resistance. Tortuosity
$\tau$
generally increases as porosity decreases, and empirical relations of the form
are commonly used (Marmet et al. Reference Marmet2023). Permeability expression with the Carman–Kozeny relation is given by
where
$d_f$
is the characteristic fibre or biocolloid diameter forming the porous network (Peach Reference Peach1991). It is noted that the Carman–Kozeny relation is most appropriate for porous media that can be idealised as a randomly packed bed or fibrous structure with well-defined structural elements (Ozgumus et al. Reference Ozgumus, Mobedi and Ozkol2014). The physically relevant range of the dimensionless ratio
$a/\ell$
in
$(0.1,10)$
captures weak-to-strong hydrodynamic pore resistance. The relation given by (3.3) yields a porosity interval of
$0.85 \lesssim \varepsilon \lesssim 0.98$
, appropriate for highly fluid saturated porous media with a weakly dense cross-linked polymer network. In practical hydrogel systems such as agarose, this porosity range maps to polymer concentrations typically between
${\sim} 0.2\,\%$
and
$1\,\%$
(w/v). For example, a
$0.2\,\%$
agarose gel exhibits a porosity
$\varepsilon \approx 0.97$
with an average pore size
$\ell \sim 200{-}400\,\mathrm{nm}$
, whereas a
$1\,\%$
gel yields
$\varepsilon \approx 0.93$
and
$\ell \sim 100{-}200\,\mathrm{nm}$
(Stellwagen & Stellwagen Reference Stellwagen and Stellwagen2009; Lazarenko et al. Reference Lazarenko, Zabashta, Honcharuk, Alekseev, Yablochkova, Vergun, Andrusenko, Lazarenko and Bulavin2025). In this framework, the electrophoretic mobility is effectively characterised by the scaled Brinkman screening length, which captures the influence of porosity and polymer volume fraction on the transport behaviour of biocolloids in the hydrogel medium. These experimentally reported values confirm that the theoretically obtained permeability interval,
$5{-}200\,\mathrm{nm}$
, is consistent with agarose hydrogel exhibiting nanoscale pore structures, potentially relevant to engineered biocolloid transport for precise drug targeting (Li & Mooney Reference Li and Mooney2016). To ensure consistency between the biocolloid size and the hydrogel microstructure, the scaled Brinkman screening length is applicable within the regime
$0.1\lt a/\ell \lt 10$
, together with the porosity range
$0.85 \lesssim \varepsilon \lesssim 0.98$
, corresponding to weak-to-strong hydrodynamic pore resistance in highly fluid-saturated porous polymer networks. This choice ensures that the model captures regimes in which the biocolloid size is comparable to, smaller than or moderately larger than the hydrogel pore size, thereby maintaining both physical relevance and mathematical consistency.
The graphical results are presented based on the following principal set of parameters: temperature
$T=298$
K, Boltzmann constant
$k_{{{B}}}=8.6173\times 10^{-5}$
eV
$\textrm {K}^{-1}$
, the absolute dielectric permittivity of vacuum
$\varepsilon _{0}=8.854\times 10^{-12}$
$\textrm {C}\textrm {V}^{-1}{\rm m}^{-1}$
and viscosity
$(\eta )$
that ranges from
$100\,{\rm to}\,300$
mPa s for agarose type hydrogel (Ghebremedhin et al. Reference Ghebremedhin, Seiffert and Vilgis2021). However, most biological samples and gels used in electrophoresis are water-based, making water the primary solvent. Using water viscosity, the conditions under which electrophoresis occurs can be standardised, making it easier to replicate and compare results across different theoretical and experimental studies. The
$\boldsymbol{E}$
-problem is solved while keeping all variables in their original dimensional form. To apply the force balance condition, we need to express the electrostatic and electrohydrodynamic forces in a dimensionless form using the appropriate scaling and non-dimensional transformations. Note that distance
$r$
, and parameters
$\ell$
and
$\kappa ^{-1}$
are scaled with
$a$
, and other variables are scaled as
\begin{eqnarray} \boldsymbol{u^{*}} &=& \frac {\boldsymbol{u}}{u_c} \quad \text{with} \quad u_c = \frac {\varepsilon _0 \varepsilon _s k^2_{{{B}}} T^2 \kappa ^2 \ell ^2}{\eta e^2 a}, \nonumber\\ \psi ^{*} &=& \frac {\psi }{\psi _c} \quad \text{with} \quad \psi _c = \frac {k_{{{B}}} T}{e}, \nonumber\\ \boldsymbol{E^*} &=& \frac {\boldsymbol{E}}{\mathrm{E}_c} \quad \text{with} \quad \textit{E}_c = \frac {k_{{{B}}} T \kappa }{e}, \nonumber \\ \sigma ^* &=& \frac {\sigma }{\sigma _c} \quad \text{with} \quad \sigma _c = \frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa }{e}, \nonumber \\ \tilde {h}^*_{nk}&=& \frac {\tilde {h}_{nk}}{h_c} \quad \text{with} \quad h_c = \frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa \ell ^2}{\eta e}, \nonumber \\ \tilde {C}^*_{{{E}}}&=& \frac {C_{{{E}}}}{C^{c}_{{{E}}}} \quad \text{with} \quad C^{c}_{{{E}}} = \frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa \ell ^2 a^2}{\eta e}, \nonumber \\ \rho ^*_f &=& \frac {\rho _{\!f}}{\rho _c} \quad \text{with} \quad \rho _c = \frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa ^2}{e}, \nonumber \\ \mu ^{*}_{{{E}}}&=& \frac {\mu _{{{E}}}}{\mu _c} \quad \text{with} \quad \mu _c = \frac {2 \varepsilon _0 \varepsilon _s k_{{{B}}} T}{3 \eta e}, \nonumber \\ \sigma _R &=&\frac {\sigma _1}{\sigma _0}. \end{eqnarray}
Henceforth, all variables are expressed in non-dimensional (scaled) form; for notational simplicity, the superscript ‘*’ is omitted.
In the context of charged hydrogels, studies by Li & Hill (Reference Li and Hill2013) and Bhattacharyya & De (Reference Bhattacharyya and De2016) report that agarose-type hydrogels, commonly employed in electrophoresis, typically exhibit fixed (negative) charge densities in the range
$10^{3} {-} 10^{5}\,\text{C m}^{-3}$
arising from the polymer skeleton. Within such charged porous environments, the applied electric field must be carefully controlled to ensure stable electrokinetic transport. Accordingly, the present study considers low to moderate electric field strengths varying from
$25\,\text{V cm}^{-1}$
to
$50\,\text{V cm}^{-1}$
, consistent with experimentally relevant conditions (Khobaib et al. Reference Khobaib, Mikkelsen, Vincent-Dospital and Rozynek2021). Maintaining a relatively low field strength is particularly important in biocolloid-based targeted drug delivery, as it facilitates controlled electrophoretic motion of charged colloidal biocolloids while minimising membrane damage or structural disruption during cellular translocation (Nakamura et al. Reference Nakamura, Okamura, Tajima, Kawano, Yamaji, Ohsaki and Watano2023). Within this framework, the following section presents a detailed graphical analysis of the influential parameters governing biocolloid design, highlighting variations in key physical parameters (as mentioned in table 1 with valid ranges) that affect its overall electrophoretic mobility. In the context of variations in biocolloid shape from a standard spherical geometry and the size of the biocolloid, particular emphasis is placed on the deformation parameter
$\epsilon$
, the scaled Brinkman screening length
$a/\ell$
, which characterises the relative size of the biocolloid with respect to the hydrogel pore size, and the ratio
$\sigma _1/\sigma _0$
, representing the nonuniformity in the surface charge distribution relative to the baseline uniform surface charge density
$\sigma _0=-0.5\,{\unicode{x03BC}} \mathrm{C\,m}^{-2}$
. The selected range of
$\sigma _1/\sigma _0$
is intended to capture weak-to-strong variations in surface charge distribution. In this context, all subsequent graphical results are generated using the ranges of dimensionless parameters and dimensional physical quantities reported in table 1.
Physically relevant parameter ranges and corresponding references.

Table 1. Long description
A table with 12 rows and 4 columns. The columns are labeled Parameter, Symbol, Parameter range, and Reference. The table lists various physical parameters relevant to biocolloids and hydrogels, including their symbols, ranges, and references. Each row provides specific details for a parameter, such as Biocolloid diameter with symbol 2a and range 5.5 nm ≤ a ≤ 200 nm, referenced from Nejati et al. (2020). Other parameters include Aspect ratio, Deformation parameter, Ionic strength, Scaled Debye length, Fixed charge density of hydrogel, Baseline surface charge density, Surface charge density non-uniformity ratio, Biocolloid dielectric constant, Hydrogel dielectric constant, Permittivity ratio, Scaled Brinkman screening length, Fluid viscosity (hydrogel), Temperature, and Applied electric field strength. Each parameter is accompanied by its respective range and reference.
3.1.
$\zeta -$
potential, Brinkmanlet, electrophoretic mobility and their qualitative validation
The present study considers
$\sigma$
as a function of
$\epsilon$
. However, the surface zeta potential of the charged biocolloids must depend on
$\sigma$
. The zeta potential is an essential factor for the stability of an electrolyte medium. The
$\zeta$
potential on the biocolloid surface can be presented in dimensional form as
Depending on the zeta potential, a charged biocolloid can achieve faster internalisation through the surface of a targeted cell. After adsorption, the biocolloid size regulates the uptake rate through endocytosis. In biocolloid-based drug delivery for cancer treatment, biocolloid size and zeta potential determine cytotoxicity. Therefore, controlling size and zeta potential is essential for the effectiveness of nanostructures (biocolloids) in drug delivery. We discuss how the shape of a biocolloid affects its zeta potential. By controlling the shape of a biocolloidal entity, it is possible to achieve a higher surface zeta potential, which can lead to improved outcomes in biocolloid-based drug delivery. Consequently, in this study, we demonstrate that a slight deformation of the biocolloid’s shape alters its surface zeta potential. Figure 2 shows the variation of
$\zeta$
potential for varying Debye lengths corresponding to different
$\epsilon$
. In this context, a charged biocolloidal entity demonstrates its prolate (oblate) nature when its major (minor) axis is oriented along the
$z$
-axis, which aligns with the direction of the electric field (see figure 1). It is noticed that a biocolloid with
$-1\lt \epsilon \lt 0$
exhibits a higher surface
$\zeta -$
potential as compared with a biocolloid with
$0\lt \epsilon \lt 1$
having the same magnitude of
$\epsilon$
. For a spherical biocolloid
$(\epsilon =0)$
, the magnitude of
$\zeta -$
potential lies between them. In other words, for aspect ratio
$b/a$
greater than unity, i.e. for a more elongated biocolloid (at higher negative values of
$\epsilon$
) along the
$z$
-axis, the surface
$\zeta$
-potential gets enhanced. In contrast, a more flattened biocolloid perpendicular to the
$z$
-axis (with a higher positive value of
$\epsilon$
) exhibits a decrease in
$\zeta$
-potential. However, during electrophoretic migration within a host, this alignment cannot be externally controlled. In this context, it is evident that a biocolloid with a prolate nature exhibits smaller surface energy, making it more stable in suspension. Therefore, under an applied electric field, an oblate-nature biocolloid tends to reorient itself to achieve a state of lower surface energy. However, this behaviour arises naturally from the physical characteristics of biocolloid shape, even though the present mathematical model does not explicitly account for biocolloid reorientation. Moreover, a decrease in surface energy reduces aggregation tendencies among the biocolloids and weakens interactions with the surrounding medium. Lastly, in figure 2, the
$\zeta $
-potential obtained from the present study for
$\epsilon =0$
is shown to coincide with that reported in a study by Li & Hill (Reference Li and Hill2013), where electrophoresis of a charged spherical biocolloid through a Brinkman medium is discussed.
Scaled
$\zeta$
-potential versus scaled Debye length
$\kappa a$
: with
$a/\ell =0.2$
;
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
for
$\epsilon =-0.2$
(prolate),
$\epsilon =-0.1$
(prolate),
$\epsilon =0$
(spherical),
$\epsilon =0.1$
(oblate),
$\epsilon =0.2$
(oblate).

We examine the influence of biocolloid shape on the hydrodynamic field in the
E
-problem using the quantity
$C_{{{E}}} = \lim _{r\rightarrow \infty }r^{2} (h_{10}+\epsilon h_{11} )$
called Brinkmanlet which quantifies electric field induced velocity and the short-range hydrodynamic screening that arises from the resistance of the polymer matrix of hydrogel (Hill Reference Hill2006a
; Hill & Ostoja-Starzewski Reference Hill and Ostoja-Starzewski2008; Li & Hill Reference Li and Hill2013; Leiderman & Olson Reference Leiderman and Olson2016). In the present context of gel electrophoresis,
$C_{{{E}}}$
quantifies how the applied electric field affects flow patterns, pressure distribution and the mobility of charged biocolloids through biologically porous environments. The analytical expression for
$C_{{{E}}}$
is derived as in the dimensionless form,
\begin{align} C_{{{E}}} &= \sigma _0 \Bigg [\mathcal{B}(\kappa a, a/\ell ,\gamma ,\rho _f/\sigma _0) \nonumber\\ &\quad -\,\mathcal{F}\!\left (\kappa a,\frac {a}{\ell },\gamma \right ) +\,\epsilon \Bigg \{ -A^{*}_{11} \left ( 3+\frac {3a}{\ell }+\frac {a^2}{\ell ^2} \right ) + \frac {1}{5} \left ( 1+\frac {a}{\ell } \right ) H_c(a) \nonumber\\ &\qquad - \frac {2}{3}\mathcal{\tilde {Q}}_{a} \left ( 1+\frac {3\ell }{a}+\frac {3\ell ^2}{a^2} \right ) -\mathcal{G}\!\left (\kappa a,\frac {a}{\ell },\gamma \right )\Bigg \}\Bigg ], \end{align}
which is valid for all possible values of
$\kappa a$
and
$a/\ell$
. Note that
$H_c(a) = \tilde {h}^{*\,\prime \prime }_{10}(1)$
is obtained from (2.36b
) (
$\tilde {h}^{*}_{nk}$
is the scaled form of
$\tilde {h}_{nk}$
, explicitly mentioned in Appendix D), and
$\mathcal{B}(\kappa a, a/\ell ,\gamma ,\rho _f/\sigma _0)$
,
$A^{*}_{11}$
,
$\mathcal{\tilde {Q}}_{a}$
,
$\mathcal{F} (\kappa a, {a}/{\ell },\gamma )$
and
$\mathcal{G} (\kappa a,{a}/{\ell },\gamma )$
are explicitly given in Appendix D. Moreover, in the case of an uncharged hydrogel, i.e.
$\rho _{\!f}=0$
, bulk ionic strength
$I$
is solely influenced by the gel’s mobile charge ions, due to vanishing
$I^{{{f}}}$
as given in (2.25d
). Hence,
$C_{{{E}}}$
becomes
\begin{align} C_{{{E}}} &= \sigma _0 \Bigg [ \mathcal{B}(\kappa a, a/\ell ,\gamma ) - \mathcal{F}\!\left (\kappa a,\frac {a}{\ell },\gamma \right ) \nonumber\\ &\quad +\, \epsilon \, \Bigg \{ -A^{*}_{11} \left ( 3+3\frac {a}{\ell }+\frac {a^2}{\ell ^2} \right ) + \frac {1}{5} \left ( 1+\frac {a}{\ell } \right ) H_{uc}(a) \nonumber\\ &\qquad - \frac {2}{3}\mathcal{\tilde {Q}}_{a} \left ( 1+3\frac {\ell }{a}+3\frac {\ell ^2}{a^2} \right ) -\mathcal{G}\!\left (\kappa a,\frac {a}{\ell },\gamma \right )\Bigg \} \Bigg ], \end{align}
where
Evidently, (3.6a
) and (3.6b
) are the equations that represent Brinkmanlet for a slightly deformed spherical non-uniformly charged biocolloid inclusion for charged and uncharged hydrogels, respectively. Hence, for a uniformly charged spherical biocolloid inclusion within an uncharged hydrogel (
$\rho _f=0$
),
$C_{{{E}}}$
becomes
\begin{align} C_{{{E}}} =\;& \frac {\sigma _0(\kappa a)^2}{\kappa a+1} \left (\frac {(a/\ell )^2}{3}+\frac {a}{\ell }+1\right ) \Bigg \{ \gamma \Bigg [ \frac {1}{3} - \frac {a}{2\ell } + \frac {\kappa a}{3} + \left (\frac {a}{\ell }\right )^2 - \frac {(\kappa a)^2}{3} - \frac {\kappa a}{2}\frac {a}{\ell } \Bigg ] \notag\\ &\qquad + \gamma E_1(\kappa a)\exp (\kappa a) \Bigg [ 1-\left (\frac {a}{\ell }\right )^3 -\frac {(\kappa a)^3}{3} +\frac {(\kappa a)^2}{2}\left (\frac {a}{\ell }\right ) \Bigg ] \notag \\ &\qquad + \exp \left (\frac {\kappa a((a/\ell )+1)}{a/\ell }\right ) E_1\!\left (\frac {\kappa a((a/\ell )+1)}{a/\ell }\right ) \Bigg [ -\frac {\kappa a}{a/\ell } +\left (\frac {a}{\ell }\right )^2\kappa a +\left (\frac {a}{\ell }\right )^3\gamma +1 \Bigg ]\Bigg \}. \end{align}
We compare the analytical expression
$C_{{{E}}}$
obtained in the present study, valid for
$\kappa a$
lying in the range (0.01, 10), as mentioned earlier, with the corresponding expressions reported by Hill (Reference Hill2006a
) and Doane et al. (Reference Doane, Cheng, Babar, Hill and Burda2010), which are given as follows:
valid for
$\kappa a \gg 1$
,
$a/\ell \gg 1$
and the low surface
$\zeta -$
potential, and
\begin{align} C_{{{E}}} = \frac {\zeta }{\kappa a} -\frac {3}{2}(\kappa a) \left ( \rho _{\!f} \right ) \left \{ \left (\frac {\ell }{a}\right )^{2} +\left (\frac {\ell }{a}\right ) +\frac {1}{3} \right \}\!, \end{align}
which is valid for
$\kappa a \ll 1$
and
$\kappa \ell \ll 1$
. The graphical results in figure 3(a) depict a comparison between the study by Hill (Reference Hill2006a
) with our computed result in a qualitative way. The obtained result given by (3.6d
) is valid for a finite range of Debye screening length lying in the range of (0.01,10). To validate this result, it is compared with the result given by (3.7a
) for
$\kappa \ell \gg 1$
and
$\kappa a \gg 1$
. Slight quantitative deviations between the Brinkmanlet coefficient (
$C_{{{E}}}$
) obtained in the present model and the same obtained by Hill (Reference Hill2006a
) arise from higher-order corrections captured in this present model beyond the leading-order thin-layer treatment. These differences become negligible in the asymptotic limit
$\kappa a \to \infty$
. In other words, the magnitude difference for the spherical biocolloid in figure 3(a) tends to diminish further for higher values of
$\kappa a$
. Similarly, for figure 3(b), we compare with the result given by (3.7b
) in the
$\kappa \ell \ll 1$
and
$\kappa a \ll 1$
limit, and obtained that in both cases, the Brinkmanlet is influenced by biocolloid shape, i.e. the decaying of far-field flow is distorted by the biocolloid geometry. In this study,
$C_{{{E}}}$
is calculated for a bare, charged biocolloid suspended in a Brinkman medium. The marginal difference in magnitude given by the blue dashed line and red solid line for the spherical biocolloid given in figure 3(b) reflects the increased frictional coupling experienced by the PEGylated biocolloid (Doane et al. Reference Doane, Cheng, Babar, Hill and Burda2010) compared with the bare biocolloid.
(a) Comparison of
$C_{{ {E}}}$
from the current study with that obtained by Hill (Reference Hill2006a
), in which
$\kappa \ell \gg 1$
and
$\kappa a \gg 1$
with
$\rho _{\!f}=0$
, and
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
. (b) Comparison of
$C_{{{E}}}$
from the current study with that obtained by Doane et al. (Reference Doane, Cheng, Babar, Hill and Burda2010), where
$\kappa \ell \ll 1$
and
$\kappa a \ll 1$
with
$\rho _{\!f}=-10^{3}$
C m
$^{-5}$
, and
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
.

Figure 3. Long description
Panel A: A line graph compares the electrophoretic coefficient from the current study with results obtained by Hill in 2006. The x-axis represents the scaled Brinkman screening length, ranging from 10 to 100. The y-axis represents the Brinkmanlet Strength, ranging from 0 to 1. The graph includes multiple lines representing different values of a parameter epsilon (0, 0.1, -0.1) and a dashed line representing Hill’s 2006 model. Trends show that as the ratio increases, the electrophoretic coefficient also increases, with variations depending on the value of epsilon. Panel B: Another line graph compares the electrophoretic coefficient from the current study with results obtained by Doane et al. in 2010. The x-axis represents the scaled Brinkman screening length, ranging from 1 to 10. The y-axis represents the Brinkmanlet Strength, ranging from 0 to 1. The graph includes multiple lines representing different values of a parameter epsilon (0, 0.1, -0.1) and a dashed line representing Doane et al.’s 2010 model. An inset zooms in on the range from 4 to 10 on the x-axis and 0.05 to 0.35 on the y-axis. Trends show that as the ratio increases, the electrophoretic coefficient decreases, with variations depending on the value of epsilon.
The present study is consistent with the study by Ohshima (Reference Ohshima2019), which describes the electrophoretic migration of a spherical charged biocolloid in a charged hydrogel with a uniform surface charge density and accounts for long-range hydrodynamic interactions between the biocolloid and the gel. Due to the limited availability of directly comparable analytical or experimental results of the present coupled configuration concerning the electrophoresis of a slightly deformed spherical biocolloid with non-uniform surface charge density in a charged hydrogel medium, a fully quantitative validation is hardly possible. Therefore, the present results are validated through comparison with the corresponding theoretical results available for spherical biocolloids with uniform surface charge density. The observed agreement in the qualitative trend of the electrophoretic mobility provides confidence in the validity and physical consistency of the present analysis. The approximated analytical expression of the electrophoretic mobility
$(\mu _{{{E}}})$
presented in the study by Ohshima (Reference Ohshima2019) (given by (75)) is compared with that obtained from the present study through figure 4(a). The variation in both electrophoretic mobilities is presented concerning
$\kappa a$
within the range
$[0.01, 10]$
for uniform surface charge density
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
and hydrogel with
$(a\ll \ell )$
. Due to the significant differences in the magnitude of electrophoretic mobility between the current study and that of Ohshima (Reference Ohshima2019), the mobility data from Ohshima (Reference Ohshima2019) are scaled to allow for a qualitative comparison with the present study without altering the trends. Ohshima (Reference Ohshima2019) derived an analytical expression for the electrophoretic mobility that involves exponential integral functions, making it cumbersome to evaluate. To address this, Ohshima (Reference Ohshima2019) proposed an approximate expression with a controlled relative error. Moreover, the analytical expression obtained in the present work does not rely on any approximation of exponential integral functions and follows directly from the governing electrokinetic equations. The complex expressions in the present model are computed in MATLAB without any approximations. The mobility expression ((
$75$
) of Ohshima Reference Ohshima2019) is itself an approximation; a direct quantitative comparison between the two results is not strictly feasible. When
$\kappa a\ll 1$
, the two graphs for spherical biocolloid as given by the black dashed line (present study) and the purple solid line (Ohshima Reference Ohshima2019) coincide. Increasing
$\kappa a$
value increases the deviation between the approximated solution and the complete general solution for a spherical biocolloid. Nevertheless, the qualitative agreement observed in the figure 4(a) confirms that both approaches capture the same underlying electrokinetic trends. Figure 4(a) illustrates the variation in
$\mu _{{{E}}}$
obtained from the present study with respect to three values of
$\epsilon = -0.1,\,0,\,0.1$
. Magnitude differences in
$\mu _{{{E}}}$
are attributed to geometric variation of the biocolloid. These three mobility curves qualitatively agree with Ohshima (Reference Ohshima2019). The biocolloid geometry influences mobility through its uniform surface charge density.
Scaled electrophoretic mobility as a function of
$(\kappa a,\epsilon )$
when (a)
$a/\ell =0.1$
,
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=0.0\,{\unicode{x03BC}}$
C m
$^{-2}$
(uniform charge density) and
$\rho _{\!f}=-10^{3}$
C m
$^{-3}$
, and comparison with the scaled electrophoretic mobility of charged biocolloid in gel-electrophoresis as reported in the study by Ohshima (Reference Ohshima2019). (b) Scaled electrophoretic mobility as a function of
$(\kappa a)$
, when
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=0.0\,{\unicode{x03BC}}$
C m
$^{-2}$
(uniform charge density), and
$\rho _{\!f}=0$
and comparison with the scaled electrophoretic mobility of charged spherical (
$\epsilon =0$
) biocolloid in an uncharged gel experimentally reported in the study by Hanauer et al. (Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007).

When
$\epsilon \lt 0$
, the biocolloid exhibits its prolate nature and can overcome the hydrogel resistance due to its elongated shape along the
$z$
-direction. Moreover, the major axis of the spheroidal biocolloid is parallel to the applied electric field. It shows higher mobility compared with the case when
$\epsilon \gt 0$
, where the biocolloid demonstrates its oblate nature with its minor axis parallel to the applied electric field. The mobility in the case of
$\epsilon = 0$
(spherical charge biocolloid) lies between them. In all the cases presented in figure 4(a),
$\mu _{{{E}}}$
decreases as
$\kappa a$
increases. As
$\kappa a$
rises, the ionic strength of the hydrogel’s electrolyte solution also increases. Consequently, the number of mobile counterions in the solution increases, enhancing the screening of the negatively charged biocolloid by the surrounding ions. The effective charges of the biocolloid reduce due to the counteraction of the nearby ions. As a result, the electrostatic force on the biocolloid reduces. At higher ionic strengths, the fixed charges within the gel lose their overall charge due to interactions with mobile counterions. These aligned dipoles create an opposing electric field, which in turn decreases the net electric field strength surrounding the fixed charges. Consequently, the combined impact of the electrostatic force and the hydrodynamic force resulting from the applied electric field on the biocolloid is substantially reduced, resulting in the surface geometry not affecting biocolloid mobility. However, in the case of
$\kappa a\ll 1$
, the number of mobile counterions is lower, and the effective dipole moment between fixed ions and mobile counterions is reduced. Also, the screening effect on the biocolloid would be less. As a result, the net electrical force and the electric field-derived hydrodynamic force would be sufficient to move the biocolloid with higher mobility. In this case, a deformed spherical biocolloid and a spherical one can be distinguished by differences in their mobilities. When
$\epsilon = -0.1$
, the biocolloid exhibits higher mobility as compared with that of
$\epsilon = 0.1$
. The biocolloid mobility corresponding to
$\epsilon = 0$
lies in between them. Therefore, the electrophoretic mobility variation depends significantly on the surface geometry of the biocolloid within hydrogels saturated with low-ionic-strength electrolytes.
Experimental validation. The electrophoretic mobility of a biocolloid is further validated by an experimental study that demonstrates the separation of gold and silver biocolloids by agarose gel electrophoresis based on their size and shape. In that experiment, the biocolloids are coated with a charged polymer and subsequently immersed in a
$0.2\,\%$
agarose gel in
$0.5\times$
TBE (Tris-borate EDTA) buffer (pH
$\sim 9$
). Hanauer et al. (Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007) calculated the mobility
$\mu ^{{\textit{{H}}}}_{{{E}}}$
for the fixed
$\zeta$
-potential using the Henry formula in dimensional form:
where
$\mathcal{H}(\kappa a)$
is the Henry correction factor accounting for the finite thickness of the Debye layer, and it is given by
\begin{align} \mathcal{H}(\kappa a)=1+\frac {1}{2\left (1+\frac {\delta '}{\kappa a}\right )^3}, \end{align}
with
In the experiment corresponding to
$\kappa a \approx 5$
, the ionic strength is approximately
$20$
mM, and agarose gel concentration
$\lt 0.5\,\%$
, giving pore diameters in the gel (
$200{-}400\,\mathrm{nm}$
) that are larger than the biocolloid radius. Therefore, the experimental configuration proposed by Hanauer et al. (Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007) provides a suitable basis for comparing and validating the mobility expression derived here for spherical biocolloids. In the experimental measurements, the biocolloid mobility is interpreted using the Henry mobility expression. At the same time, electroosmotic flow generated by the surface potential contributes primarily as a constant background mobility offset of order
$\varepsilon _0\varepsilon _s\zeta /\eta$
. Therefore, to validate the mobility expression derived in the present study against the experimental results (Hanauer et al. Reference Hanauer, Pierrat, Zins, Lotz and Sönnichsen2007), a uniform surface charge density is assumed for the spherical biocolloid. To validate the result, the
$\zeta$
-potential is calculated from surface charge density using the relation given by (3.5). Furthermore, for the comparison shown in figure 4(b),
$\sigma _0=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
is chosen, ensuring consistency throughout the present study. The present study treats a spherical biocolloid as a bare charged biocolloid, without explicitly accounting for the polymer coating. In contrast, the experimental study involves biocolloids with a polyethylene glycol layer. The polymer coating effectively modifies the frictional coupling, which can lead to a slight deviation in the magnitude of the mobility, as observed in figure 4(b). Nevertheless, the qualitative agreement indicates that the experimental configuration closely corresponds to the theoretical framework for the uncharged gel in the Stokes limiting regime considered in the present study.
3.2. Electrostatic potential and nonuniform surface charge density
Without an external electric field, the electrostatic potential around the biocolloid is shaped by its surface charge, the fixed charges of the polymer skeleton of the hydrogel and its geometry. In the case of
$\epsilon \neq 0$
, the biocolloid exhibits the highest curvature near its poles; consequently, they can accumulate surface charges densely in these regions, while the surface charges near the equator are more spread out. On the one hand, when
$\epsilon = 0$
, the uniform curvature in the biocolloid geometry leads to a uniform accumulation of surface charges. Figures 5(a), 5(c) and 5(e) illustrate the electrostatic potential surrounding the biocolloid when
$\kappa a \ll 1$
, corresponding to
$\epsilon = 0.2$
,
$\epsilon = 0.0$
and
$\epsilon = -0.2$
, respectively. When
$\kappa a \ll 1$
, in figures 5(c) and 5(e), the counterions are less dense, creating a diffuse layer of ions. Consequently, counterions tend to neutralise surface charges, leading to weak electrostatic screening and a high potential in the immediate vicinity of the surface. On the other hand, figures 5(b), 5(d) and 5(f) illustrate the electrostatic potential around the biocolloid for the case where
$\kappa a \gg 1$
, representing values of
$\epsilon = 0.2$
,
$\epsilon = 0.0$
and
$\epsilon = -0.2$
. From figures 5(d) and 5(f), it can be seen that increasing salt concentration in gel (
$\kappa a \gg 1$
) can increase the neutralisation of surface charges more effectively. As a result, the strong localised screening effect can induce a comparatively small surface potential.
Electrostatic potential for the combinations of scaled Debye length
$\kappa a$
and deformation parameter
$\epsilon$
when (a)
$\kappa a\ll 1$
and
$\epsilon =0.2$
(oblate shape), (b)
$\kappa a\gg 1$
and
$\epsilon =0.2$
(oblate shape), (c)
$\kappa a\ll 1$
and
$\epsilon =0$
(spherical shape), (d)
$\kappa a\gg 1$
and
$\epsilon =0$
(spherical shape), (e)
$\kappa a\ll 1$
and
$\epsilon =-0.2$
(prolate shape), (f)
$\kappa a\gg 1$
and
$\epsilon =-0.2$
(prolate shape), given
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\rho _{\!f}=-10^{3}$
C m
$^{-3}$
and
$a\ll l$
.

Figure 5. Long description
Panel A: A heat map showing electrostatic potential for a combination of scaled Debye length and deformation parameter with an oblate shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 3.0 times 10^-3, with red indicating higher values and blue indicating lower values. The potential is highest around the central oblate shape and decreases outward. Panel B: A heat map showing electrostatic potential for a different combination of scaled Debye length and deformation parameter with an oblate shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 0.010, with red indicating higher values and blue indicating lower values. The potential is highest around the central oblate shape and decreases outward. Panel C: A heat map showing electrostatic potential for a combination of scaled Debye length and deformation parameter with a spherical shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 9 times 10^-3, with red indicating higher values and blue indicating lower values. The potential is highest around the central spherical shape and decreases outward. Panel D: A heat map showing electrostatic potential for a different combination of scaled Debye length and deformation parameter with a spherical shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 9 times 10^-3, with red indicating higher values and blue indicating lower values. The potential is highest around the central spherical shape and decreases outward. Panel E: A heat map showing electrostatic potential for a combination of scaled Debye length and deformation parameter with a prolate shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 0.12, with red indicating higher values and blue indicating lower values. The potential is highest around the central prolate shape and decreases outward. Panel F: A heat map showing electrostatic potential for a different combination of scaled Debye length and deformation parameter with a prolate shape. The X and Z axes range from -2.0 to 2.0. The color scale ranges from 0 to 0.020, with red indicating higher values and blue indicating lower values. The potential is highest around the central prolate shape and decreases outward.
However, this scenario changes significantly in figures 5(a) and 5(b), due to the high curvature dominance around the equatorial region of biocolloids (
$\epsilon \gt 0$
). In the case of
$\kappa a \ll 1$
, thin charge clouds are observed at poles and equators. However, when
$ \kappa a \gg 1$
, the charge clouds rotate by
$45^\circ$
with respect to the
$ z$
-axis and they become thicker. Each of the purple-, green-, indigo blue- and yellow-shaded regions has increased thickness due to variations in the salt concentration added to the hydrogel network. In the thin Debye limit, it shows a higher localised surface potential than in the thick Debye limit, though it rapidly decays beyond the Debye layer thickness. However, in figures 5(c) and 5(d), the spherical biocolloids accumulate uniform surface charge density (
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
,
$\sigma _1=0.0 \,{\unicode{x03BC}}$
C m
$^{-2}$
), resulting in a uniform potential distribution irrespective of Debye layer thickness limit. In later sections, an elaborate discussion of how the non-uniformity of surface charges is influenced by the external field strength, the immobile charge in the gel and their combined effect on electrophoretic mobility is presented.
3.3. Non-uniform surface charge density and biocolloid mobility
In figure 6(a,b), the electrophoretic mobility in the dilute gel (
$a\ll \ell$
) varies under an external electric field depending on the value of
$\left |\sigma _{1} - \sigma _{0}\right |$
, where
$\rho _{\!f} \sim 10^{3}$
C m
$^{-3}$
. As previously stated,
$\sigma _0$
represents the baseline uniform surface charge density, while
$\sigma _1$
is introduced due to a perturbation in the geometry. In figure 6(a), the relative shift of surface charge density from baseline is given by
$\left |\sigma _{1} - \sigma _{0}\right |$
. Now, when
$\sigma _{1} - \sigma _{0}\gt 0$
, then the perturbed surface charge enhances the net charge density. The local electric field concentrates at the pole along the positive
$z$
direction for the biocolloid with
$\epsilon =-0.2$
, resulting in a boost in the electrostatic potential. In contrast, for
$\epsilon =0.2$
, the local electric field becomes comparatively weaker near the surface region of the biocolloid. As a result of both non-uniform surface charge distribution and surface geometry variation, a significant variation in the net electrical forces (purely electrostatic force and electric field-induced hydrodynamic force) corresponding to
$\epsilon =-0.2$
and
$\epsilon =0.2$
occurs, which results in a marked difference in the electrophoretic mobility. However, when
$\sigma _{1}-\sigma _{0}\leq 0$
, the baseline uniform surface charges
$\sigma _{0}$
try to dominate the charged biocolloid movement. Both tend to lose non-uniform charge domination, resulting in a small mobility difference for
$\epsilon =-0.2$
and
$\epsilon =0.2$
.
Scaled electrophoretic mobility as a function of
$\kappa a$
and shape deformation parameter
$\epsilon$
: for the various situations corresponding to non-uniform surface charge densities displayed in panels (a), (b) and (c). Three situations corresponding to different values of
$\sigma _{1}/\sigma _{0}$
for a biocolloid with prolate and oblate shapes are displayed in all the figures where
$\rho _{\!f}= -1\times 10^{3}$
C m
$^{-3}$
.

A visual focusing on
$\sigma _{1}/\sigma _{0}$
is presented in figure 6(b). For biocolloids with
$\epsilon =-0.2$
and
$\epsilon =0.2$
, if the baseline surface charge density is fixed to a specific value, then parameter
$\sigma _{1}$
dictates whether the non-uniformity of charge distribution is amplified or suppressed. Therefore, an increase in
$\sigma _{1}/\sigma _{0}$
values results in a higher difference in the mobility between the cases
$\epsilon =-0.2$
and
$\epsilon =0.2$
. The mobility behaviour corresponding to a ratio of
$\sigma _{1}/\sigma _{0}$
up to
$2$
is presented here. However, beyond
$\sigma _{1}/\sigma _{0}=2$
, this phenomenon continues to persist up to a much higher magnitude of
$\sigma _{1}/\sigma _{0}$
. Nevertheless, when
$\sigma _{1}/\sigma _{0}=0.01$
, the influence of non-uniform surface charge distribution is very low. In this case, both biocolloids with
$\epsilon =-0.2$
and
$\epsilon =0.2$
carry the same effective net charge density, and when
$\kappa a \geqslant 1$
(thin double layer regime), shape effects on the biocolloid’s surface potential are negligible due to electrostatic screening by the counterions in the hydrogel.
A comprehensive discussion of the sign variation associated with the non-uniform surface charge contribution,
$\sigma _{1}$
, is presented based on figure 6(c). For biocolloids with
$\epsilon =-0.2,\,0.2$
and
$\sigma _{0}=-0.5\,{\unicode{x03BC}}$
C m
$^{-2}$
, the non-uniform charge distribution parameter
$\sigma _{1}$
plays a decisive role in determining the role reversal aspect of the electrophoretic mobility based on the biocolloid orientation in the applied electric field. In the case of
$\epsilon =-0.2$
(prolate), when
$\sigma _{1}\lt 0$
, the perturbation counteracts the baseline distribution by reducing charge density at the poles, thereby weakening the curvature-induced field amplification. However, for
$\sigma _{1}\gt 0$
, the scenario changes as
$\sigma _{1}$
reinforces
$\sigma _{0}$
, amplifying the curvature-induced field effects. However, in the case of
$\epsilon =0.2$
(oblate), the phenomenon gets reversed. Note that we consider
$\sigma _{1}=0.3\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _{1}=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
for the first and second cases, respectively. When
$\sigma _{1}=0$
, the distribution of surface charges is uniform, both biocolloids with
$\epsilon =-0.2$
and
$\epsilon =0.2$
carry the same effective net charge density, and when
$\kappa a \geqslant 1$
(thin double layer regime), the influence of biocolloid shape on the surface potential becomes negligible, since the electrostatic screening suppresses curvature effects due to the increased counterions in the charged hydrogel. In cases of
$\sigma _{1} \lessgtr 0$
, the difference in mobility between biocolloids with
$\epsilon = -0.2$
and
$\epsilon = 0.2$
is found to be greater than that of a biocolloid with a uniform surface charge density
$(\sigma _{1} = 0)$
. However, in the
$\kappa a \geqslant 1$
regime, the geometric influence on mobility becomes negligible for prolate and oblate biocolloids in the case of uniform surface charge density.
Scaled electrophoretic mobility as a function of
$a/\ell$
and deformation parameter
$\epsilon$
, for the combinations (a)
$\kappa a\ll 1$
and
$\rho _{\!f}=-1\times 10^{5}$
C m
$^{-3}$
high, (b)
$\kappa a\ll 1$
and
$\rho _{\!f}=-1\times 10^{3}$
C m
$^{-3}$
low, and (c)
$\kappa a\gg 1$
and
$\rho _{\!f}=-1\times 10^{5}$
C m
$^{-3}$
high, (d)
$\kappa a\gg 1$
and
$\rho _{\!f}=-1\times 10^{3}$
C m
$^{-3}$
low, when
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
.

Figure 7. Long description
The image contains four line graphs labeled (a), (b), (c), and (d), each depicting the scaled electrophoretic mobility (μE) as a function of the scaled Brinkman screening length (a/ℓ). Panel A: The line graph shows the relationship for high ρf and low ka. The x-axis represents the scaled Brinkman screening length (a/ℓ) on a logarithmic scale ranging from 0.1 to 10, and the y-axis represents the scaled electrophoretic mobility (μE) ranging from 0.4 to 1.8. Three lines are plotted for different values of ε (-0.2, 0, and 0.2), showing a decreasing trend with increasing a/ℓ. Panel B: The line graph shows the relationship for low ρf and low ka. The x-axis represents the scaled Brinkman screening length (a/ℓ) on a logarithmic scale ranging from 0.1 to 10, and the y-axis represents the scaled electrophoretic mobility (μE) ranging from 0 to 30. Three lines are plotted for different values of ε (-0.2, 0, and 0.2), showing a decreasing trend with increasing a/ℓ. Panel C: The line graph shows the relationship for high ρf and high ka. The x-axis represents the scaled Brinkman screening length (a/ℓ) on a logarithmic scale ranging from 0.1 to 10, and the y-axis represents the scaled electrophoretic mobility (μE) ranging from 1.7 to 1.9. Three lines are plotted for different values of ε (-0.2, 0, and 0.2), showing a non-monotonic trend with a minimum around a/ℓ approximately equal to 2. Panel D: The line graph shows the relationship for low ρf and high ka. The x-axis represents the scaled Brinkman screening length (a/ℓ) on a logarithmic scale ranging from 0.1 to 10, and the y-axis represents the scaled electrophoretic mobility (μE) ranging from 15 to 35. Three lines are plotted for different values of ε (-0.2, 0, and 0.2), showing a non-monotonic trend with minima around a/ℓ approximately equal to 0.38 and 1.88.
3.4. Brinkman screening length and biocolloid mobility
The electrophoretic mobility typically decreases as the biocolloid radius increases relative to the Brinkman screening length in Brinkman-type biological media, particularly for spherical charged biocolloids (Li & Hill Reference Li and Hill2013). The Brinkman screening length characterises the sharp decay of the velocity field in a Brinkman medium. In addition to electromigration of the biocolloid under an applied electric field, it experiences drag due to the surrounding motion of the hydrogel. For instance, when
$ a/\ell \ll 1$
, the flow around the biocolloid is less hindered, allowing for more unrestricted movement. In contrast, when
$ a/\ell \gg 1$
, the flow decays rapidly around the biocolloid, resulting in greater resistance to its motion. Therefore, this classical result indicates that the electrophoretic mobility of a biocolloid decreases as the
$a/\ell$
ratio increases. As reported by Li & Hill (Reference Li and Hill2013), dimensionless scaled electrophoretic mobility for a charged spherical colloidal biocolloid is found to decrease with
$a/\ell$
within a Brinkman medium through the relation
\begin{align} \mu _{{{E}}}\sim \frac {1}{\left [1+\left (\frac {a}{\ell }\right )+\frac {1}{9}\left (\frac {a}{\ell }\right )^{2}\right ]}. \end{align}
However, in this article, we examine changes in these classical scenarios under various circumstances. We discuss the scaled mobility behaviour of the biocolloid in relation to the ratio
$a/\ell$
across four scenarios: (i)
$\kappa a \ll 1 \ \text{ and high}\,\rho _{\!f}$
; (ii)
$\kappa a \ll 1 \text{ and low}\,\rho _{\!f}$
; (iii)
$\kappa a \gg 1\,\text{and high}\,\rho _{\!f}$
; and (iv)
$\kappa a \gg 1\,\text{and low}\,\rho _{\!f}$
, through figure 7(a–d), respectively. Three values of
$\epsilon$
are considered here:
$\epsilon = -0.2 \,\text{(prolate with major axis parallel to } z\text{-axis)}$
,
$\epsilon = 0 (\text{spherical})$
and
$\epsilon = 0.2 \,\text{oblate with minor axis parallel to }z\text{-axis}$
. For all these values, the mobility decreases within
$a/\ell \in [0.1,\,10]$
. When
$\kappa a \ll 1\, \text{and}\,\rho _{\!f}$
is high, figure 7(a) illustrates the occurrence of higher and lower mobility for
$\epsilon = -0.2$
and
$\epsilon = 0.2$
, respectively, for
$0.1\leq a/\ell \leq 2.0$
. Beyond
$a/\ell = 2.0$
, this trend becomes opposite, whereas for a spherical biocolloid (
$\epsilon = 0$
), mobility lies between the mobilities of biocolloids with
$\epsilon = -0.2$
and
$\epsilon = 0.2$
. Moreover, the porous nature of the gel matrix acts as a sieving medium, slowing the passage of biocolloids based on their size. Specifically,
$a\lt \ell$
corresponds to larger pore sizes in gels, which provide less resistive drag force for fluid transport and, consequently, allow for greater mobility. The alignment of biocolloids
$(\epsilon \lt 0)$
with their major axis aligned with the electric field minimises hindrance, resulting in higher mobility. Moreover, biocolloid mobility is hindered by the strong repulsion between the fixed charges on the gel network and the biocolloid surface charge. However, when
$\kappa a \ll 1$
, the diffused ionic cloud surrounding the biocolloid becomes thinner in the case of
$\epsilon = -0.2$
compared with when
$\epsilon = 0.2$
. The higher fixed-charge density of the gel strengthens the electrostatic field surrounding the gel, thereby enhancing the attraction between the fixed charges and counterions in the surrounding solution. This stronger attraction leads to more significant counterion condensation near the gel’s charged surfaces, as outlined previously (Manning Reference Manning2011; Hsu & Lee Reference Hsu and Lee2012; Dey et al. Reference Dey, Raja Sekhar and Burada2018). As a result, the interaction between the ionic cloud (Debye layer) containing the counterions and the fixed charges on the gel skeleton becomes less in the former case than in the latter. Additionally, the biocolloid with
$\epsilon \lt 0$
can accumulate more surface charges, interacting more with the surrounding medium’s fixed charges, which leads to a more substantial electric repulsion on the biocolloid compared with more compact shapes like
$\epsilon \geq 0$
. However, as
$a/\ell \gt 2.0$
, the gel-pore size is reduced. Now, due to the increase in the interaction between the counterions and the fixed charges on the gel skeleton, the mobility hindrance due to the repulsion effect between the charged biocolloid and the gel fixed charges becomes reduced. Therefore, the biocolloid with
$\epsilon = 0.2$
shows higher mobility as compared with that with
$\epsilon = -0.2$
, when
$a/\ell \gt 2.0$
. Therefore, when
$\kappa a \ll 1\, \text{and}\,\rho _{\!f}$
is high, there exists a threshold value
$a/\ell =2$
such that the impact of biocolloid geometry on the mobility can be illustrated. It is also worth mentioning that the biocolloid with
$\epsilon = 0.2$
should experience a larger drag as compared with
$\epsilon = -0.2$
due to a larger surface area exposed towards the hydrodynamic force (induced by the applied electric field) along the
$z\text{-}$
direction (i.e. the direction of the applied electric field). Overall, the discussion can be concluded through a remark that when
$\kappa a \ll 1\, \text{and}\,\rho _{\!f}$
is high, the biocolloid mobility is shape dependent. Figure 7(b) shows the variation in biocolloid mobility with
$a/\ell$
when
$\kappa a \ll 1$
and
$\rho _{\!f}$
is low, indicating that biocolloid mobility cannot be distinguished based on shape. Within the range
$a/\ell \in [0.1,\,10 ]$
, the biocolloid in this context shows identical mobility corresponding to
$\epsilon = -0.2,\,0,\,0.2$
. In this situation, a weak repulsion arises between the charged biocolloid and the fixed charges on the gel network, as the Debye layer surrounding the biocolloid thickens. Overall, we observe a high mobility magnitude for all these cases.
Next, we consider the situation of biocolloid mobility variation with respect to
$a/\ell$
when
$\kappa a \gg 1\,\text{and}\,\rho _{\!f}$
is high in figure 7(c). Due to the high concentration of added salt, the screening effect between the gel counterions and the fixed charges becomes significantly stronger, as does the screening effect between the counterions and the charged biocolloid. In this situation, the electrical force on the biocolloid drops significantly. In this case, the weak repulsion effect between the gel-fixed charges and the charged biocolloid also prevents the biocolloid mobility from being hindered. However, we observe a reduced magnitude of mobility in all cases of
$\epsilon = -0.2,\,0,\,0.2$
, with the highest and lowest mobilities of the biocolloid corresponding to
$\epsilon = -0.2$
and
$\epsilon = 0.2$
, respectively, throughout the aforementioned range of
$a/\ell$
. However, the biocolloid cannot experience a sufficient force to produce significant mobility. In such a case, the biocolloid mobility can be differentiated by the deformation parameter
$\epsilon$
. However, the variation in the mobility magnitudes is relatively less with respect to
$a/\ell$
. They drop slightly with increasing
$a/\ell$
up to a specific value,
$a/\ell \sim 5$
, after which they tend to saturate to some value.
Figure 7(d) combines the phenomena as seen through figure 7(a–c), where
$\kappa a \gg 1 \text{and}\,\rho _{\!f}$
is low. The large number of counterions from the added salt can easily neutralise the low-charged gel network. Addditionally, these counterions screened the biocolloid; however, it experienced a significant drag force while moving through the hydrogel network, without experiencing any retardation due to repulsion. Hence, a high mobility magnitude is observed. In this case, we may locate three regimes of
$a/\ell$
such as
$[0.1,\,0.37)$
,
$[0.38,\,1.87)$
and
$[1.88,\,10]$
, where we can experience three variations in mobility. For instance, when
$a/\ell$
is in the range
$[0.1,\,0.37)$
, the biocolloid with
$\epsilon = -0.2$
exhibits the highest mobility, whereas that with
$\epsilon = 0.2$
displays the lowest. The case where
$\epsilon = 0$
lies in between these two extremes. This situation becomes opposite in the second case when
$a/\ell \in [0.38,\,1.87)$
. Again, the first situation repeats when
$a/\ell \in [1.88,\,10]$
, but a larger difference in the mobility due to the variation in
$\epsilon$
can be seen. The alteration in biocolloid mobility due to shape variation is primarily attributed to changes in the Brinkman screening length.
Scaled electrophoretic mobility as a function of
$a/\ell$
, when (a)
$\kappa a\ll 1$
and (b)
$\kappa a\gg 1$
, for the various combinations of deformation parameter
$\epsilon$
and fixed charge density
$\rho _{\!f}$
of the polymer skeleton within the gel-like media, corresponding to the scale of
$-10^{3}$
C m
$^{-3}$
, given
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
.

In the four graphical results, we examine four limiting cases of the parameters
$\kappa a$
and
$\rho _{\!f}$
. Next two graphical results figure 8(a–b) illustrate the behaviour of
$\rho _{\!f}$
for two limiting cases:
$\kappa a\ll 1$
and
$\kappa a\gg 1$
. A specific fixed value of
$\rho _{\!f}$
yields different mobility curves for these cases. For a wide region of
$a/\ell$
in
$[0.1,\,10]$
, we find similar phenomena influencing the geometry-dependent biocolloid mobility. Here, we illustrate the simultaneous influence of deformation parameter
$\epsilon$
and fixed charge density
$\rho _{\!f}$
for
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
in a thick and thin Debye layer limit. Irrespective of the ionic concentration of the hydrogel, the increase in fixed charges in the gel leads to an increase in electrostatic repulsion near the poles for both biocolloids, with
$\epsilon \lt 0$
and
$\epsilon \gt 0$
. In the former case, the poles accumulate a surface charge density that is screened by gel counterions. So, the net electric influence on the surface gets decayed. Similar phenomena are seen for the latter. However, when
$\kappa a \ll 1$
, the screening effect becomes insignificant to distinguish the biocolloid mobility with
$\epsilon = -0.2$
from that with
$\epsilon = 0.2$
due to a smaller number of counterions. We observe a marginal mobility difference for biocolloids with
$\epsilon = -0.2$
and
$\epsilon = 0.2$
throughout the range
$a/\ell$
in
$[0.1,\,10]$
, attributed to the hydrodynamic influence. When the ionic concentration is high, the applied electric field can distinguish the mobilities of biocolloids, and the continuous competition between electrostatic repulsion and electrokinetic effects results in a cross-over in the mobility curves. However, the existence of crossovers becomes prominent in the case of
$\rho _{\!f}=-0.5\times 10^{3}$
C m
$^{-3}$
, but not in the other cases except when
$a/\ell \gt 1$
. The electrohydrodynamic drag influences the biocolloid mobility in this case. The biocolloid with
$\epsilon = -0.2$
exhibits better pore mobility through the charged polymer skeleton of the hydrogel in comparison with
$\epsilon = 0.2$
. Even one can see the increase in pore mobility of the biocolloid irrespective of the shape with a higher scaled Brinkman screening length for
$\rho _{\!f}=-0.5\times 10^{3}$
C m
$^{-3}$
. Therefore, for
$\kappa a\gg 1$
, the shape influence continues to affect biocolloid mobility throughout the region of
$a/\ell$
in
$[0.1,\,10]$
. However, for
$\kappa a\ll 1$
, mobilities coincide for different values of
$\rho _{\!f}$
irrespective of shape dependency.
3.5. Electrophoretic mobility and relative permittivity
To study a variety of biocolloids and hydrogel systems, we select
$\lambda = \varepsilon _{p}/\varepsilon _{s}$
within the range
$0 \lt \lambda \lt 10$
. This approach allows us to explore the dependence of electrophoretic mobility on dielectric constants. A detailed discussion will focus on
$\epsilon$
,
$a/\ell$
,
$\rho _{\!f}$
,
$\sigma _{0}$
and
$\sigma _{1}$
in the two limiting cases of
$\kappa a \ll 1$
and
$\kappa a \gg 1$
, as well as for a wide range of
$\kappa a$
. Figures 9(a) and 9(b) compellingly showcase the relationship between
$\mu _{{{E}}}$
and the relative permittivity
$\varepsilon _{p}/\varepsilon _{s}$
for different
$\rho _{\!f}$
values, corresponding to
$\kappa a \ll 1$
and
$\kappa a \gg 1$
, respectively. At low values of
$\rho _{\!f}$
, the larger ionic atmosphere is highly sensitive to the dielectric constant of biocolloids. This results in enhanced mobility trends due to curvature effects caused by deformation. In contrast, at high
$\rho _{\!f}$
, the ionic environment is primarily influenced by ion-induced dipoles. In this case, mobility is marginally dependent on the biocolloid shape. However, an extensive range of relative permittivity is considered in the two above-mentioned graphical results. The shape of a biocolloid influences its mobility and the nonlinear mobility arises from variations in relative permittivity. This variation becomes significant when the ratio
$\varepsilon _{p}/\varepsilon _s$
exceeds
$10$
. Irrespective of ionic concentration, saturation in electrophoretic mobility is attained at a lower relative permittivity when the hydrogel’s fixed charge density is low. Here, dielectric constants modify electric fields near-surface weakly, so mobility shows dependence on
$\varepsilon _{p}/\varepsilon _s$
. However, strongly charged gels provide additional electro-osmotic assistance, raising the baseline mobility relative to weakly charged gels. Geometric curvature dominates the overall mobility. Therefore, the mobility difference between the two biocolloids tends to increase with increasing fixed charge, approaching the thick- and thin-Debye-layer limits. The mobility magnitude is higher in the latter case than in the former.
Scaled electrophoretic mobility as a function of the permittivity ratio
$(\varepsilon _{p}/\varepsilon _{s})$
and the fixed charge density
$\rho _{\!f}$
of the polymer skeleton within the gel-like media, when (a)
$\kappa a \ll 1$
, (b)
$\kappa a \gg 1$
, for the various combinations of deformation parameter
$\epsilon$
and fixed charge density
$\rho _{\!f}$
of the polymer skeleton within the gel-like media, corresponding to the scale of
$-10^{3}$
C m
$^{-3}$
, given
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
.

Scaled electrophoretic mobility as a function of permittivity ratio
$(\varepsilon _{p}/\varepsilon _{s})$
with non-uniform surface charge densities as described in terms of
$\sigma _{1}/\sigma _{0}$
for the biocolloid with
$\epsilon =-0.2$
and
$\epsilon =0.2$
shapes is described for the situations (a)
$\kappa a \ll 1$
, (b)
$\kappa a \sim 1$
and (c)
$\kappa a \gg 1$
. (d) Scaled electrophoretic mobility for various
$\kappa a$
in the case of the prolate and oblate shaped biocolloid with uniform surface charge density.

Figure 10. Long description
The image contains four panels, each depicting a line graph that shows the scaled electrophoretic mobility as a function of the permittivity ratio. Panel A: This line graph shows the scaled electrophoretic mobility for biocolloids with non-uniform surface charge densities. The x-axis represents the permittivity ratio, and the y-axis represents the scaled electrophoretic mobility. The graph includes multiple lines representing different surface charge density ratios and electric field strengths. Panel B: This line graph also shows the scaled electrophoretic mobility for biocolloids with non-uniform surface charge densities but under different conditions. The x-axis represents the permittivity ratio, and the y-axis represents the scaled electrophoretic mobility. The graph includes multiple lines representing different surface charge density ratios and electric field strengths. Panel C: This line graph shows the scaled electrophoretic mobility for biocolloids with non-uniform surface charge densities under different conditions. The x-axis represents the permittivity ratio, and the y-axis represents the scaled electrophoretic mobility. The graph includes multiple lines representing different surface charge density ratios and electric field strengths. Panel D: This line graph shows the scaled electrophoretic mobility for biocolloids with uniform surface charge densities. The x-axis represents the permittivity ratio, and the y-axis represents the scaled electrophoretic mobility. The graph includes multiple lines representing different shapes of biocolloids and varying electric field strengths.
The influence of non-uniform surface charge density on biocolloid mobility, resulting from changes in dielectric constants for
$\kappa a \ll 1$
,
$\kappa a \sim 1$
and
$\kappa a \gg 1$
, is illustrated graphically in figure 10(a–c). The non-uniformity of surface charge density is given by (2.7), while the ratio
$\sigma _1/\sigma _0$
is assumed to lie within the range
$(0.01,\,10)$
. In the absence of an applied electric field, dielectric constants and surface charge density satisfy a relationship at the boundary given by (2.24). Since the induced electrostatic potential is directly proportional to
$\gamma ={(1-\lambda )}/{(2+\lambda )}$
, the relative permittivity directly controls both the sign and magnitude of induced multipolar corrections to the surface potential. These induced corrections amplify or suppress the exterior potential generated by any free surface non-uniformity of
$\sigma$
. When
$\kappa a \ll 1$
, strong nonlinear mobility trends emerge because the diffuse ionic cloud extends significantly, allowing non-uniform charge distributions to couple with the electrostatic field strongly. This pronounced nonlinearity is characteristic of the
$\kappa a \ll 1$
regime. Now, increasing
$\sigma _1/\sigma _0$
from 0.1 to 10, the mobility for
$\epsilon =-0.2$
decreases, but for
$\epsilon =0.2$
, the trend reverses, i.e. mobility increases because of the curvature influence. The difference in mobility between biocolloids with
$\epsilon =-0.2$
and
$\epsilon =0.2$
is significantly greater for
$\sigma _1/\sigma _0=0.1$
compared with
$\sigma _1/\sigma _0=10$
.
In the scenario where
$\kappa a \sim 1$
(see figure 10
b), the mobility trends with varying dielectric constants for
$\epsilon =-0.2$
and different ratios of
$\sigma _1/\sigma _0$
show a consistent pattern. This pattern is similar to what is observed for
$\epsilon =-0.2$
in figure 10(a), where
$\kappa a \ll 1$
. However, for
$\epsilon =0.2$
, we do not see a comparable relationship between the cases
$\kappa a \ll 1$
and
$\kappa a \sim 1$
. The change in
$\sigma _1/\sigma _0$
becomes highly sensitive to biocolloid mobility when studying variations in medium dielectric constants, as
$\varepsilon _{p}/\varepsilon _{s}$
ranges within
$(0.01,\,10)$
. Here, biocolloid shape, dielectric mismatch and ionic screening all play equal roles in determining electrophoretic mobility. Specifically, in the cross-over regimes (as shown in figure 10
b), mobility trends are sensitive to parameter changes. Corresponding to
$\kappa a\gg 1$
, figure 10(c) shows that the electric double layer is strongly compressed. The ionic cloud forms a thin layer that tries to neutralise the overall surface charge. We observe that mobility trends become linear with respect to the relative permittivity. The difference in biocolloid mobility for
$\epsilon =-0.2$
and
$\epsilon =0.2$
at
$\sigma _1/\sigma _0=0.1$
becomes small because the influence of non-uniform surface charge density
$\sigma _1$
on biocolloid geometry becomes negligible. Conversely, when
$\sigma _1$
becomes more dominant over
$\sigma _0$
, the difference in mobility for
$\epsilon =-0.2$
and
$\epsilon =0.2$
increases. Across these three graphs, we can see an increase in mobility magnitude as the added salt concentration increases.
In figure 10(d), we focus on the results as ionic strength increases from low to high, keeping the surface charge density uniform (
$\sigma _1=0$
). This shows graphically that increasing salt concentration widens the difference between the mobility trends for
$\epsilon =-0.2$
and
$\epsilon =0.2$
. When
$\kappa a\ll 1$
, the ions are diffused in the solution. Here,
$\lambda = (\varepsilon _{p}/\varepsilon _{s} )$
has only a weak effect, because most of the potential drop happens in the diffuse region, not right at the near-surface region. In this region, the flow is mainly dominated by surface potential. So, due to the lack of influence of the non-uniform surface charge, the difference between the mobility graphs for both the biocolloids
$\epsilon =-0.2$
and
$\epsilon =0.2$
is minimal. The permittivity ratio’s influence on mobility becomes negligible in the
$\kappa a\ll 1$
regime. However, increasing ionic strength makes the Debye layer more densely confined to the biocolloid surface. An increased number of counter-ions tends to neutralise the surface charges, but here the permittivity ratio
$\lambda$
amplifies the mobility difference in
$\kappa a\gg 1$
.
3.6. Stream function U-problem
The deformed geometry of the sphere alters the flow field, as captured through the following stream function:
The streamlines around a deformed sphere (in figure 11) will deviate from those around a perfect sphere, showing complex flow patterns. Here, the scenario involves only viscous hydrodynamic drag. When the hydrogel pore size is much larger than the biocolloid radius (
$\ell \gg a$
), the biocolloid moves more readily and is primarily influenced by viscous forces. In the absence of an electric field, the hydrodynamic force (represented through (2.53d
)) contains an extra
$\epsilon$
dependency term due to deformation in geometry. Since the drag depends on the projected area and curvature distribution relative to flow direction (here in the
$z$
-direction), biocolloids with
$-1\lt \epsilon \lt 0$
experience less drag due to their elongated shape near the poles. However, this scenario changes when
$0\lt \epsilon \lt 1$
for a biocolloid whose major axis is perpendicular to the flow direction.
Stream function
$\psi ^{{{U}}}$
corresponding to the
$\boldsymbol{U}$
-problem with
$a\ll \ell$
for (a)
$\epsilon =-0.3$
(prolate), (b)
$\epsilon =0$
(spherical) and (c)
$\epsilon =0.3$
(oblate).

The oblate shape experiences increased drag due to its larger surface area facing the flow. The negative streamline value near the pole region in figure 11(c) denotes opposite backflow flux. As a result, biocolloids with
$0\lt \epsilon \lt 1$
in figure 11(c) experience higher hydrodynamic resistance compared with the biocolloids with
$-1\lt \epsilon \lt 0$
in figure 11(a). Because of the symmetrical geometry of spherical biocolloids (where
$\epsilon = 0$
), the volumetric flux is distributed uniformly. Consequently, in figure 11(b), streamlines merely deform around the body without producing closed near-surface recirculation loops.
Stream function
$\psi ^{{{E}}}$
corresponding to the
$\boldsymbol{E}$
-problem with
$a\gg \ell$
for (a)
$\epsilon =-0.3$
(prolate), (b)
$\epsilon =0$
(spherical) and (c)
$\epsilon =0.3$
(oblate)
$\rho _{\!f}=-1\times 10^{3}$
C m
$^{-3}$
, when
$\sigma _0=-0.2\,{\unicode{x03BC}}$
C m
$^{-2}$
and
$\sigma _1=-0.1\,{\unicode{x03BC}}$
C m
$^{-2}$
.

Figure 12. Long description
Panel A: A contour plot shows the stream function for a prolate-shaped biocolloid. The X and Z axes range from -3 to 3. The contours are labeled with numerical values indicating the stream function levels. Panel B: A contour plot displays the stream function for a spherical biocolloid. The X and Z axes range from -3 to 3. The contours are labeled with numerical values indicating the stream function levels. Panel C: A contour plot illustrates the stream function for an oblate-shaped biocolloid. The X and Z axes range from -3 to 3. The contours are labeled with numerical values indicating the stream function levels.
3.7. Stream function E-problem
When an external electric field is applied along the
$z$
-direction, the motion of biocolloids depends on the accumulation of surface charges, interactions with the hydrogel and the thickness of the Debye layer. In the
$\boldsymbol{E}$
-problem, the stream function around a slightly deformed sphere immersed in a charged Brinkman medium is given by
Therefore, electro-hydrodynamic effects influence the velocity field surrounding the biocolloid. The stream function given by (3.13) accounts for both the electrostatic and hydrodynamic contributions under an external electric field. In the low-permeability charged hydrogel,
$a\gg \ell$
indicates that the electric field significantly influences the electrolyte medium that saturates the hydrogel. The biocolloid with
$-1\lt \epsilon \lt 0$
has significant curvature along the poles, which intensely concentrates the electric field lines, but a small tangential component because the electric field lines are perpendicular to the surface, resulting in a negligible tangential component. It drives a strong electro-hydrodynamic flow outwards from the poles, as shown in figure 12(a). Conversely, a biocolloid with
$0\lt \epsilon \lt 1$
has a large lateral surface area oriented perpendicular to the applied electric field. Due to this orientation, the motion is dominated by the hydrodynamic force induced by the electric field in the region
$a\gg \ell$
. The characteristics of the local volumetric flux generated by electro-hydrodynamic flow are described by the sign and magnitude of the stream function presented in (3.13). In figure 12(c), the streamlines show positive values in the equatorial region, indicating that fluid flows outward from the equator towards the poles. Therefore, increased local volumetric flux results in larger streamline magnitudes that enclose the biocolloid surface. Consequently, the intense electro-hydrodynamic flow generates strong recirculation zones. As this fluid flow converges towards the poles, the streamline pattern shows flow separation and a narrow wake behind the biocolloid. Eddy structures and back-circulation loops are present in these wakes. At the poles, the tangential electric field is weak, leading to stagnant zones where streamlines detach from the surface. In contrast, a biocolloid with
$-1 \lt \epsilon \lt 0$
shows negative streamlines near the poles, indicating flux in the opposite direction. Here, the electric field is aligned with the major axis, reducing the tangential electric field strength and, therefore, weakening the net electro-hydrodynamic force. This phenomenon leads to narrower wakes with weaker eddy structures. Both shapes have stagnation zones where the flow velocity is zero and the streamlines do not touch the surface. For spherical biocolloid
$\epsilon =0$
, the stream function is given by
As a sphere possesses uniform curvature throughout, the higher-order terms of
$\epsilon$
disappear, as shown in (3.14). Consequently, the flow patterns do not include any closed recirculation loops, as depicted in figure 12(b). Therefore, due to the symmetry of geometry, the hydrodynamic flow induced by the electric field influences the spherical biocolloid in all directions uniformly. Therefore, no eddies formed, i.e. the streamline pattern is distributed in such a way that the local fluid velocity does not reverse direction relative to the main flow.
4. Summary
This study discusses the migration of a charged, slightly deformed biocolloid through a charged porous hydrogel under a weak electric field across a wide range of Debye lengths. The biocolloid considered here exhibits a low induced potential near its surface, with a non-uniform surface charge density that depends on the parameter, suggesting a deviation from spherical symmetry. Consequently, the deformation of the Debye layer caused by polarisation from the convection and electromigration of ions is not considered. Additionally, the relaxation through molecular diffusion of ions and their interactions within the charged gel, along with the slightly altered spherical shape of the surface, are also ignored. We find that size selectivity is achievable, regardless of its complexity, even when the biocolloid has a non-uniform charge density. Without an external field, curvature-induced charge localisation causes significant potential differences in slightly deformed spherical shapes, whereas spherical biocolloids exhibit nearly uniform potentials regardless of ionic strength. Precisely, it is seen that in the case of a thin Debye layer, a biocolloid exhibiting a prolate
$(\epsilon \lt 0)$
nature has higher mobility than an oblate
$(\epsilon \gt 0)$
; however, a spherical biocolloid possesses an intermediate mobility. Nevertheless, this nature may be reversed for larger Debye lengths beyond some value of the dimensionless/scaled Brinkman screening length (for example,
$a/\ell \sim 2$
). Such scenarios can be depicted from our study as follows.
-
(i) In a broader sense, irrespective of biocolloid shape, its mobility within a hydrogel saturated with a low-ionic-strength electrolyte
$(\kappa a \ll 1)$
decreases with increasing Brinkman screening length. The biocolloid in this context exhibits a high mobility magnitude
$(\mu _{{{E}}}\sim 10)$
and shape-independent mobility when the hydrogel’s fixed charge density is of order
$10^{3}\, \textrm {C}\,\textrm {m}^{-3}$
(low fixed charge density). -
(ii) However, the shape-dependent biocolloid mobility is predominant in a hydrogel with a high fixed-charge density
$(\rho _{\!f}\sim 10^{5}\, \textrm {C}\,\textrm {m}^{-3})$
saturated with an electrolyte of moderate ionic strength. Nevertheless, the mobility magnitude remains significantly low
$(\mu _{{{E}}}\sim 1)$
. To achieve high mobility in this situation, the hydrogel’s fixed charge density should be low
$(\rho _{\!f}\sim 10^{3}\, \textrm {C}\,\textrm {m}^{-3})$
. Moreover, at this stage, when the scaled Brinkman screening length exceeds
$1.88$
(i.e.
$a/\ell \geqslant 1.88$
), the possibility of achieving shape-dependent mobility with a significantly larger magnitude
$(\mu _{{{E}}}\sim 10)$
increases. -
(iii) The orientation-dependent mobility variations among slightly deformed spherical biocolloids prevail, corresponding to the scaled Debye length ranges
$\kappa a \ll 1$
and
$\kappa a \gg 1$
, when the dielectric constant ratio between the biocolloid and the hydrogel is significantly high
$\varepsilon _{p}/\varepsilon _{s} \gt 10$
. However, in contrast, the biocolloids and hydrogel system satisfying the dielectric constant ratio
$\varepsilon _{p}/\varepsilon _{s} \leq 10$
does not exhibit any mobility difference, irrespective of the orientation. Nevertheless, in such cases, the mobility difference is readily apparent when the hydrogel’s fixed charges are weak. -
(iv) At constant hydrogel fixed charge density, slightly deformed spherical biocolloids
$(\epsilon =-0.2,\,0.2)$
with a higher surface charge non-uniformity (i.e.
$\sigma _{1}/\sigma _{0}\gt 1$
) exhibit stronger orientation-dependent mobility differences for a large variety of the Debye length
$10^{-2}\leq \kappa a \leq 10^{1}$
considered in this study. However, a complete opposite trend in the mobility variation with respect to
$\sigma _{1}/\sigma _{0}$
is intensified with the effect of increasing ionic strength. Moreover, in the case of a uniformly charged biocolloid
$(\sigma _{1}=0)$
having a slightly deformed spherical shape, the mobility distinction based on the orientation of biocolloids is not as prominent as compared with that of the case of a non-uniform surface charge density.
5. Conclusion
Overall observations suggest that a slightly deformed biocolloid, oriented as prolate
$(\epsilon \lt 0)$
with respect to the applied electric field, typically exhibits better mobility than an oblate
$(\epsilon \gt 0)$
biocolloid, except in certain situations. Clearly, the enhanced mobility of non-spherical biocolloids compared with spherical shapes can be a significant tool for nanostructure design to improve drug targeting. However, the orientation of a non-spherical biocolloid in an applied electric field cannot be controlled from outside the system. The drug delivery process based on theranostic biocolloids can achieve higher mobility efficacy when a drug is formulated in equal proportions of spherical and deformed-spherical forms, rather than using either form alone. Since premature elimination of drug-loaded bare rigid biocolloids from the bloodstream leads to off-target release of therapeutic agents, reducing the efficacy of drug delivery to tumour cells, a polyelectrolyte layer-coated biocolloid with a hydrophobic or hydrophilic surface can be considered to overcome this limitation by controlling its interaction with the surrounding biological fluid and cellular environment. However, the mobility of such a biocolloid may be influenced by deformation of the hydrogel’s polymer skeleton, which represents a potential scope for further study. In addition, addressing the strong, diffusion-dominated polarisation effects and the surface potential difference arising from surface adsorption (Donnan potential), which deviates biocolloids from their expected behaviour, could significantly improve size-based sorting. However, in biocolloid-based targeted drug delivery via electrophoresis, the applied electric field strength should be low enough to facilitate controlled movement, allowing charged colloidal biocolloids to cross cell membranes without causing damage or disruption (Nakamura et al. Reference Nakamura, Okamura, Tajima, Kawano, Yamaji, Ohsaki and Watano2023).
Acknowledgements
N.K. acknowledges the University Grants Commission (UGC), Govt. of India, for providing her the Senior Research Fellowship (Joint CSIR-UGC, Award Letter Ref. 201610093816, Dated 01.04.2021, Roll No: WB10607881).
Declaration of interests
The authors have no conflicts to disclose.
Data availability statement
The data that support the findings of this study, are available from the corresponding author upon reasonable request.
Author contributions
N.K.: Conceptualisation (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Software (lead); Validation (equal); Visualisation (equal); Writing - original draft (equal); Writing - review & editing (equal). J.P.: Conceptualisation (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Software (lead); Validation (equal); Visualisation (equal); Writing - original draft (equal); Writing - review & editing (equal). B.D.: Conceptualisation (equal); Formal analysis (equal); Investigation (equal); Validation (equal); Writing - original draft (equal); Writing - review & editing (equal).
Appendix A. Arbitrary constants in the electrostatic potential
Appendix B. Arbitrary constants in the
$\boldsymbol{U}$
-problem
\begin{align} b_{31} &= -\frac {2}{15} \frac {15+ 15\frac {a}{\ell } + 6\left (\frac {a}{\ell }\right )^2+\left (\frac {a}{\ell }\right )^3}{3 + 3\frac {a}{\ell } + \left (\frac {a}{\ell }\right )^2} \left (a^4\ell ^2 h''_{10}(a)\right )\!, \\[-12pt]\nonumber\end{align}
\begin{align} d_{31} &= -\frac {2}{15}a^2 \left (\frac {1}{1 + 3\frac {\ell }{a} + 3\frac {\ell ^2}{a^2}}\right ) \exp \left (\frac {a}{\ell }\right ) h''_{10}(a).\end{align}
Appendix C
C.1. Arbitrary constant values in
$\tilde {h}_{10}$
\begin{align} \tilde {a}_{10} &= -\frac {3}{2} \left ( \frac {\rho _f \ell ^2}{\eta } \right ) - \int _{a}^{\infty } \frac {\sigma _0}{\eta } \frac {(\kappa a)^2}{\kappa a + 1} \exp \!\Bigg [ \kappa a \Big ( 1 - \frac {r}{a} \Big ) \Bigg ] \left ( \frac {\kappa a}{\frac {r}{a}} + \frac {1}{\left ( \frac {r}{a} \right )^2} \right ) \left ( 1 + \frac {\gamma }{\left ( \frac {r}{a} \right )^3} \right )\times \frac {r}{3 \left ( 1 + r \frac {a}{\ell } \right )} \, {\rm d}r , \nonumber \\ \tilde {b}_{10} &= a^3 \Bigg [ - \tilde {a}_{10} \Bigg ( \left ( \frac {\ell }{a} \right )^2 + \frac {\ell }{a} + \frac {1}{3} \Bigg ) \Bigg ] , \nonumber \\ \tilde {d}_{10} &= a \, \tilde {a}_{10} \, \exp \left ( \frac {a}{\ell } \right ) \!, \end{align}
where the particular solution in
$\tilde {h}_{10}$
is given by
\begin{align} F_{10}(r;\kappa a,\gamma )&= r \int _{a}^{r} F_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{1,{{{F}}}} \, {\rm d}r' +\frac {1}{r^2} \int _{a}^{r} F_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{2,{{{F}}}} \, {\rm d}r' \nonumber\\ &+ \frac {\ell (r + \ell )}{r^2} \exp \left (-\frac {r}{\ell } \right ) \int _{a}^{r} F_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{3,{{{F}}}} \, {\rm d}r'. \end{align}
Here, the Wronskian functions
$W_{1,{{{F}}}}$
,
$W_{2,{{{F}}}}$
and
$W_{3,{{{F}}}}$
are given by
\begin{eqnarray} W_{1,{{{F}}}} &=& \frac {r}{3\left (1 + \frac {r}{\ell } \right )}, \nonumber \\ W_{2,{{{F}}}} &=& \frac {r^2\ell ^2} { \left (1 + \frac {r}{\ell }\right )} \left ( 1 + \frac {r}{\ell } + \frac {1}{3} \left ( \frac {r}{\ell } \right )^2 \right )\!, \nonumber \\ W_{3,{{{F}}}} &=& \frac {r^2}{\left (1 + \frac {r}{\ell }\right )}\exp \left ( \frac {r}{\ell } \right )\!, \end{eqnarray}
respectively. The integrand
$F_0 (({r}/{a}),\kappa a,\gamma )$
has the following form:
\begin{align} F_0\left (\frac {r}{a};\kappa a,\gamma \right )=\frac {\sigma _0}{\eta }\frac {\left (\kappa a\right )^2}{\kappa a+1}\exp \left (\kappa a\left (1-\frac {r}{a}\right )\right )\left (\frac {\kappa a}{\frac {r}{a}}+\frac {1}{\left (\frac {r}{a}\right )^2}\right )\left (1+\frac {\gamma }{(\frac {r}{a})^3}\right )\!. \end{align}
C.2. Arbitrary constant values in
$\tilde {h}_{11}$
\begin{align} \tilde {a}_{11} &= -\int _{a}^{\infty } \frac {\sigma _0}{\eta } \frac {(\kappa a)^2 \exp \!\left [\kappa a \left (1-\frac {r}{a}\right )\right ]} {3\left (1+\left (\frac {a}{\ell }\right )\frac {r}{a}\right )} \nonumber \\ &\times \bigg [ \frac {9\left (\kappa a\frac {r}{a}+1\right )}{10(\kappa a+1)} \left (\frac {r}{a}\right )^5 \nonumber \\ &\quad -\frac {1}{3} \big ((\kappa a)^2+2\kappa a+2+\sigma _R\big ) \left (1+\frac {\gamma }{\left (\frac {r}{a}\right )^3}\right ) \left (\frac {\kappa a}{\frac {r}{a}}+\frac {1}{\left (\frac {r}{a}\right )^2}\right ) \nonumber \\ &\quad -\frac {2}{15} \left (1+\frac {\gamma }{\left (\frac {r}{a}\right )^3}\right ) \left ( \frac {(\kappa a)^2+2\kappa a+2}{\kappa a+1} +\sigma _R \right ) \nonumber \\ &\qquad \times \frac { (\kappa a)^3\left (\frac {r}{a}\right )^3 +4(\kappa a)^2\left (\frac {r}{a}\right )^2 +9\kappa a\left (\frac {r}{a}\right ) +9 }{ \left (\frac {r}{a}\right )^4 \left ((\kappa a)^3+4(\kappa a)^2+9\kappa a+9\right ) } \bigg ] \nonumber \\ &\times \frac {r}{3\left (1+r\left (\frac {a}{\ell }\right )\right )}\,{\rm d}r , \end{align}
\begin{align} \tilde {b}_{11} &= \frac {1}{5}\left (\frac {\ell }{a}+\frac {\ell ^{2}}{a^{2}}\right )a\tilde {h}''_{10}(a)+ (2aQ_{a}(\kappa a,\gamma )-\tilde {a}_{11}) \left (1+3\left (\frac {\ell }{a}\right )+3\left (\frac {\ell }{a}\right )^2\right )Q_{a}(\kappa a,\gamma ) \end{align}
and
\begin{align} \tilde {d}_{11} = \left (-\frac {1}{5} a^2 \tilde {h}''_{10}(a) -\frac {2}{1+\frac {a}{\ell }}\left (\frac {\ell ^2}{a}\right )\times \left (1+\frac {a}{\ell }+\frac {1}{3}\left (\frac {a}{\ell }\right )^2\right )Q_{a}(\kappa a,\gamma ) + 3a \tilde {a}_{11}\right ) \exp \left (\frac {a}{\ell }\right )\!, \end{align}
where
And, the particular solution in
$\tilde {h}_{11}$
for
$\mathcal{O(\epsilon )}$
is given by
\begin{align} F_{11}(r;\kappa a,\gamma ) &= r \int _{a}^{r} Q_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{1,{{{Q}}}} \, {\rm d}r' + \frac {1}{r^2} \int _{a}^{r} F_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{2,{{{Q}}}} \, {\rm d}r' \nonumber \\ & + \frac {\ell (r + \ell )}{r^2} \exp \left ( -\frac {r}{\ell } \right ) \int _{a}^{r} F_0\left ( \kappa a, \gamma , \frac {r'}{a} \right ) W_{3,{{{Q}}}} \, {\rm d}r' , \end{align}
where
$W_{1,{{{Q}}}}$
,
$W_{2,{{{Q}}}}$
and
$W_{3,{{{Q}}}}$
are the Wronskian functions given by
\begin{align} W_{1,{{{Q}}}} &= \frac {r}{3\left (1 + \frac {r}{\ell } \right )}, \nonumber \\ W_{2,{{{Q}}}} &= \frac {r^2\ell ^2} { \left (1 + \frac {r}{\ell }\right )} \left ( 1 + \frac {r}{\ell } + \frac {1}{3} \left ( \frac {r}{\ell } \right )^2 \right )\!, \nonumber \\ W_{3,{{{Q}}}} &= \frac {r^2\exp \left ( \frac {r}{\ell } \right )}{\left (1 + \frac {r}{\ell }\right )}, \end{align}
respectively. The integrand
$Q_0 (( {r}/{a}); \kappa a, \gamma )$
is given by
\begin{eqnarray} Q_0\left (\frac {r}{a}; \kappa a, \gamma \right ) &=& \frac {\sigma _0}{\eta }\exp \left [ \kappa a \left (1 - \frac {r}{a} \right ) \right ] \bigg [ \frac {9\left ( \kappa a\left (\frac {r}{a}\right ) + 1 \right )}{10 \left (\kappa a + 1\right )} \left ( \frac {r}{a} \right )^5 \nonumber \\ && - \frac {1}{3} \left ( (\kappa a)^2 + 2\kappa a + 2 + \sigma _R \right ) \left ( 1 + \frac {\gamma }{\left ( \frac {r}{a} \right )^3} \right ) \left ( \frac {\kappa a}{\frac {r}{a}} + \frac {1}{\left ( \frac {r}{a} \right )^2} \right ) \nonumber \\ && - \frac {2}{15} \left ( 1 + \frac {\gamma }{\left ( \frac {r}{a} \right )^3} \right ) \left ( \frac {\kappa a^2 + 2\kappa a + 2}{\kappa a + 1} + \sigma _R \right ) \\ \nonumber && \times \frac { (\kappa a)^3 \left ( \frac {r}{a} \right )^3 + 4(\kappa a)^2 \left ( \frac {r}{a} \right )^2 + 9\kappa a\frac {r}{a} + 9 } { \left ( \frac {r}{a} \right )^4 \left ( (\kappa a)^3 + 4(\kappa a)^2 + 9\kappa a + 9 \right ) } \bigg ]. \end{eqnarray}
C.3. Arbitrary constant values in
$\tilde {h}_{31}$
\begin{eqnarray} \tilde {a}_{31} &=& -\int _{a}^{\infty } \bigg [ \frac {\sigma _0}{\eta }\, \exp \left ( \kappa a \left (1 - \frac {r}{a} \right ) \right ) \left ( \left ( \frac {\kappa ^2a^2 + 2\kappa a + 2}{\kappa a + 1} + \sigma _R \right ) \frac { \kappa ^3a^3 \left ( \frac {r}{a} \right )^3 + 4\kappa ^2a^2 \left ( \frac {r}{a} \right )^2 + 9\kappa a \left ( \frac {r}{a} \right ) + 9 } { \left ( \frac {r}{a} \right )^4 \left ( \kappa ^3a^3 + 4\kappa ^2a^2 + 9\kappa a + 9 \right ) } \right ) \nonumber \\ && \times \left ( 1 + \frac {\gamma }{\left ( \frac {r}{a} \right )^3} \right ) + \frac {12 \gamma \kappa ^2a^2}{5 (4 + 3\lambda )(\kappa a + 1)} \, \exp \left ( \kappa a \left (1 - \frac {r}{a} \right ) \right ) \left ( \frac {\kappa a}{\left ( \frac {r}{a} \right )^6} + \frac {1}{\left ( \frac {r}{a} \right )^7} \right ) \bigg ] \nonumber \\ && \times \frac { \left ( \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2 + 3 \left ( \frac {r}{a} \right ) \left ( \frac {a}{\ell } \right ) + 3 \right ) }{ 7 \left ( \frac {r}{a} \right )^4 \left [ 6 \left ( \frac {r}{a} \right )^2 \left (\frac {a}{\ell }\right )^2 + \left ( \frac {r}{a} \right )^3 \left (\frac {a}{\ell }\right )^3 + 15 \left ( \frac {r}{a} \right ) \left (\frac {a}{\ell }\right ) + 18 \right ] } \, {\rm d}r, \end{eqnarray}
where
\begin{align} X_a(\kappa a, a/\ell ,\gamma )=&\frac {2\sigma _0}{7\eta }\left [ - \frac {2(\kappa a)^2}{15}(1 + \gamma ) \left (\frac {(\kappa a)^2 + 2\kappa a + 2}{\kappa a + 1} +\sigma _R\right ) + \frac {12\gamma (\kappa a)^2}{5 (4 + 3\lambda )} \right ]\nonumber \\ &\quad \times \frac { \left (\dfrac {a}{\ell }+\dfrac {105\ell ^2}{a^2}+\dfrac {105\ell ^3}{a^3}\right ) }{ \left (\dfrac {6\ell }{a}+\dfrac {15\ell ^2}{a^2}+\dfrac {18\ell ^3}{a^3}+1\right ) }. \end{align}
Similarly for the particular solution in
$\tilde {h}_{31}$
for
$\mathcal{O(\epsilon )}$
is given by
\begin{align} F_{31}(r;\kappa a,\gamma ) &= r^3 \int _{a}^{r} H\left (\kappa a,\frac {r'}{a},\gamma \right ) W_{1,{{{H}}}} \, {\rm d}r' + \frac {1}{r^4} \int _{a}^{r} H\left (\kappa a,\frac {r'}{a},\gamma \right ) W_{2,{{{H}}}} \, {\rm d}r' \nonumber \\ &+ k_3\left (\frac {r}{\ell }\right )\int _{a}^{r} H\left (\kappa a,\frac {r'}{a},\gamma \right ) W_{3,{{{H}}}} \, {\rm d}r', \end{align}
where the Wronskian functions
$W_{1,{{{H}}}}$
,
$W_{2,{{{H}}}}$
and
$W_{3,{{{H}}}}$
are given by
\begin{align} &\qquad \qquad W_{1,{{{H}}}}=\frac {\ell ^3 \left ( \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2 + 3\left (\frac {r}{a}\right )\left (\frac {a}{\ell }\right ) + 3 \right ) }{ 7r \left ( 6 \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2 + \left ( \frac {r}{a} \right )^3 \left ( \frac {a}{\ell } \right )^3 + 15\frac {a}{\ell }\frac {r}{a} + 18 \right ) }, \\[-12pt]\nonumber \end{align}
\begin{align} & W_{2,{{{H}}}}=\frac { \left (r^4\ell ^2\right ) \left [ \left ( \frac {r}{a} \right )^4 \left ( \frac {a}{\ell } \right )^4 + 10 \left ( \frac {r}{a} \right )^3 \left ( \frac {a}{\ell } \right )^3 + 45 \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2 + 105 \left ( \frac {r}{a} \right ) \left ( \frac {a}{\ell } \right ) \right ]}{ \left (18 + \left ( \frac {r}{a} \right )^3 \left ( \frac {a}{\ell } \right )^3 + 15 \left ( \frac {r}{a} \right ) \left ( \frac {a}{\ell } \right ) + 6 \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2\right ) }, \\[-12pt]\nonumber \end{align}
\begin{align} &\qquad W_{3,{{{H}}}} = \left (\frac {r^4}{\ell ^2}\right ) \frac { \exp \left ( \left (\frac {a}{\ell }\right )\left (\frac {r}{a}\right ) \right ) }{\left (6 \left ( \frac {r}{a} \right )^2 \left ( \frac {a}{\ell } \right )^2 + \left ( \frac {r}{a} \right )^3 \left ( \frac {a}{\ell } \right )^3 + 15 \left ( \frac {r}{a} \right ) \left ( \frac {a}{\ell } \right ) + 18\right )}, \end{align}
respectively, where the integrand
$H (({r}/{a}); \kappa a, \gamma )$
present in
$F_{31}(r;\kappa a,\gamma )$
is given by
\begin{align} H\left ( \kappa a, \frac {r}{a}, \gamma \right ) &= \frac {\sigma _0 \kappa ^2}{\eta } \, \exp \left [ \kappa a \left (1 - \frac {r}{a} \right ) \right ] \bigg \{ -\frac {2}{15} \left ( \frac { \kappa ^2 a^2 + 2\kappa + 2 }{ \kappa a + 1 } + \sigma _R \right ) \frac { \kappa ^3 a^3 \left ( \frac {r}{a} \right )^3 + 4\kappa ^2 a^2 \left ( \frac {r}{a} \right )^2 + 9\kappa a \left ( \frac {r}{a} \right ) + 9 }{ \left ( \frac {r}{a} \right )^4 \left ( \kappa ^3 a^3 + 4\kappa ^2 a^2 + 9\kappa a + 9 \right ) } \nonumber \\ & \times \left ( 1 + \frac {\gamma }{\left ( \frac {r}{a} \right )^3} \right ) + \frac {12 \gamma \kappa ^2 a^2}{5 (4 + 3\lambda )(\kappa a + 1)} \, \exp \left [ \kappa a \left (1 - \frac {r}{a} \right ) \right ] \left ( \frac { \kappa a }{ \left ( \frac {r}{a} \right )^6 } + \frac {1}{ \left ( \frac {r}{a} \right )^7 } \right ) \bigg \}. \end{align}
Appendix D.
Expression appearing in
$\boldsymbol{C_{E}}$
Note that
Equation (D1) can be scaled using
$\tilde {h}^{*}_{nk} ={\tilde {h}_{nk}}/{h_c} \ \text{with} \ h_c = {\varepsilon _0 \varepsilon _s k_{{ {B}}} T \kappa \ell ^{2}}/{\eta e}$
. Consequently, it is rewritten as follows:
\begin{align} \tilde {h}^{*}_{nk}=\frac {{\tilde {h}_{nk}}(r)}{\frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa \ell ^{2}}{\eta e}}=\frac {1}{\frac {\varepsilon _0 \varepsilon _s k_{{{B}}} T \kappa \ell ^{2}}{\eta e}}\Bigg ({\tilde {a}_{nk}r^{n}}+\tilde {b}_{nk}\left (\frac {1}{r^{n+1}}\right )+{\tilde {c}_{nk}}i_{n}((r/\ell ))+{\tilde {d}_{nk}}k_{n}((r/\ell ))+ F_{nk}\Bigg ), \end{align}
where the explicit expressions of
$\tilde {a}_{nk}$
,
$\tilde {b}_{nk}$
$\tilde {d}_{nk}$
and
$F_{nk}$
are mentioned in Appendix C.
The expression
$\mathcal{B}(\kappa a, a/\ell ,\gamma ,\rho _f/\sigma _0)$
,
$A^{*}_{11}$
,
$\mathcal{F}\! (\kappa a, ( {a}/{\ell }), \gamma )$
,
$\tilde {Q}_{a}$
,
$\mathcal{G}\! (\kappa a, ( {a}/{\ell }), \gamma )$
appearing in
$C_{{{E}}}$
are mentioned elaborately as follows:
\begin{align} \begin{aligned} \mathcal{B}(\kappa a, a/\ell ,\gamma ,\rho _f/\sigma _0) &= \frac {3}{2} \frac {\rho _f}{\sigma _0} \left ( \kappa a \right ) \Bigg ( \frac {1}{3} + \frac {\ell }{a} + \left (\frac {\ell }{a}\right )^2 \Bigg ) \\ &\quad + \int _{1}^{\infty } \Bigg (\frac {(\kappa a)^2}{\kappa a + 1} \exp \Big (\kappa a (1 - r)\Big ) \Bigg (\frac {\kappa a}{r} + \frac {1}{r^2}\Bigg ) \Big ( 1 + \frac {\gamma }{r^3} \Big ) \\ &\quad \times \frac {r}{\displaystyle 1 + r\left (\frac {a}{\ell }\right )}\Bigg )\Bigg (1+ \frac {a}{\ell } +\frac {1}{3} \left (\frac {a}{\ell }\right )^2 \Bigg ) \, {\rm d}r. \end{aligned} \end{align}
For an uncharged gel (
$\rho _f=0$
), (D3a
) reduces to
\begin{align} \begin{aligned} \mathcal{B}(\kappa a, a/\ell ,\gamma ) &= \int _{1}^{\infty } \bigg (\frac {(\kappa a)^2}{\kappa a + 1} \exp \Big (\kappa a (1 - r)\Big ) \bigg (\frac {\kappa a}{r} + \frac {1}{r^2}\bigg ) \Big ( 1 + \frac {\gamma }{r^3} \Big ) \\ &\quad \times \frac {r}{\displaystyle 1 + r\left (\frac {a}{\ell }\right )}\bigg )\bigg (1+ \frac {a}{\ell } +\frac {1}{3} \left (\frac {a}{\ell }\right )^2 \bigg ) \, {\rm d}r, \end{aligned} \end{align}
\begin{align} \begin{aligned} A^{*}_{11} &= -\int _{1}^{\infty } \exp [\kappa a (1-r)] \Bigg [ \frac {9(\kappa a r + 1)}{10(\kappa a + 1)}\, r^{5} -\frac {1}{3} \big((\kappa a)^2 + 2\kappa a + 2 + \sigma _R \big) \left (1 + \frac {\gamma }{r^{3}}\right ) \left (\frac {\kappa a}{r} + \frac {1}{r^{2}}\right ) \\ &\quad -\frac {2}{15} \left (1 + \frac {\gamma }{r^{3}}\right ) \left (\frac {(\kappa a)^2 + 2\kappa a + 2}{\kappa a + 1} + \sigma _R \right )\times \frac {(\kappa a)^3 r^{3} + 4(\kappa a)^2 r^{2} + 9\kappa a r + 9} {r^{4}\left ((\kappa a)^3 + 4(\kappa a)^2 + 9\kappa a + 9\right )}\Bigg ]\times \frac {r}{3\left (1 + r\left (\frac {a}{\ell }\right )\right )} \, {\rm d}r , \end{aligned} \end{align}
\begin{align} \mathcal{F}\!\left (\kappa a, \frac {a}{\ell }, \gamma \right ) = \int _{1}^{\infty } \frac {(\kappa a)^2}{\kappa a+1}\exp (\kappa a(1-r))\left (\frac {\kappa a}{r}+\frac {1}{r^2}\right )\left (1+\frac {\gamma }{r^3}\right )\times \Bigg (\frac {r^2} {\left (1 + \frac {r}{\ell }\right )} \left ( 1 + r\left (\frac {a}{\ell }\right ) + \frac {1}{3} r^2\left (\frac {a}{\ell }\right )^2 \right )\Bigg )\,{\rm d}r, \end{align}
and
\begin{align} \mathcal{G}\!\left (\kappa a, \frac {a}{\ell }, \gamma \right ) &= \int _{1}^{\infty } \exp [\kappa a (1-r)] \Bigg [ \frac {9(\kappa a r + 1)}{10(\kappa a + 1)}\, r^{5} -\frac {1}{3}\big ((\kappa a)^2 + 2\kappa a + 2 + \sigma _R \big ) \left (1 + \frac {\gamma }{r^{3}}\right ) \left (\frac {\kappa a}{r} + \frac {1}{r^{2}}\right ) \nonumber \\ &\quad -\frac {2}{15} \left (1 + \frac {\gamma }{r^{3}}\right ) \left (\frac {(\kappa a)^2 + 2\kappa a + 2}{\kappa a + 1} + \sigma _R \right )\times \frac {(\kappa a)^3 r^{3} + 4(\kappa a)^2 r^{2} + 9\kappa a r + 9} {r^{4}\left ((\kappa a)^3 + 4(\kappa a)^2 + 9\kappa a + 9\right )} \Bigg ] \nonumber \\ &\quad \times \frac {r}{3\left (1+r\left (\frac {a}{\ell }\right )\right )}\,{\rm d}r . \end{align}

z

ζ
κa
a/ℓ=0.2
σ0=−0.5μ
−2
σ1=−0.2μ
−2
ϵ=−0.2
ϵ=−0.1
ϵ=0
ϵ=0.1
ϵ=0.2
CE
κℓ≫1
κa≫1
ρf=0
σ0=−0.5μ
−2
σ1=−0.2μ
−2
CE
κℓ≪1
κa≪1
ρf=−103
−5
σ0=−0.5μ
−2
σ1=−0.2μ
−2
(κa,ϵ)
a/ℓ=0.1
σ0=−0.5μ
−2
σ1=0.0μ
−2
ρf=−103
−3
(κa)
σ0=−0.5μ
−2
σ1=0.0μ
−2
ρf=0
ϵ=0
κa
ϵ
κa≪1
ϵ=0.2
κa≫1
ϵ=0.2
κa≪1
ϵ=0
κa≫1
ϵ=0
κa≪1
ϵ=−0.2
κa≫1
ϵ=−0.2
σ0=−0.2μ
−2
σ1=−0.1μ
−2
ρf=−103
−3
a≪l
κa
ϵ
σ1/σ0
ρf=−1×103
−3
a/ℓ
ϵ
κa≪1
ρf=−1×105
−3
κa≪1
ρf=−1×103
−3
κa≫1
ρf=−1×105
−3
κa≫1
ρf=−1×103
−3
σ0=−0.2μ
−2
σ1=−0.1μ
−2
a/ℓ
κa≪1
κa≫1
ϵ
ρf
−103
−3
σ0=−0.2μ
−2
σ1=−0.1μ
−2
(εp/εs)
ρf
κa≪1
κa≫1
ϵ
ρf
−103
−3
σ0=−0.2μ
−2
σ1=−0.1μ
−2
(εp/εs)
σ1/σ0
ϵ=−0.2
ϵ=0.2
κa≪1
κa∼1
κa≫1
κa
ψU
U
a≪ℓ
ϵ=−0.3
ϵ=0
ϵ=0.3
ψE
E
a≫ℓ
ϵ=−0.3
ϵ=0
ϵ=0.3
ρf=−1×103
−3
σ0=−0.2μ
−2
σ1=−0.1μ
−2